| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein phosphatase binding | MFHAS1 INSR CTTNBP2NL MAP3K5 PIK3R2 DLG4 VCP MTMR4 CDC5L CTNND1 CABIN1 AKAP1 | 6.43e-06 | 210 | 231 | 12 | GO:0019903 |
| GeneOntologyMolecularFunction | structural molecule activity | RPL24 EPPK1 MATN2 SPTB INSR EVPL DST COL21A1 JAG1 DLG4 PLEC VCL KRT4 COL6A3 COL7A1 COL9A2 COL6A6 RPL14 CLDN8 THBS3 MRPS11 MACF1 CROCC RPL8 MYBPC1 MYBPC2 | 1.45e-05 | 891 | 231 | 26 | GO:0005198 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.57e-05 | 28 | 231 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | double-stranded RNA adenosine deaminase activity | 2.98e-05 | 6 | 231 | 3 | GO:0003726 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | PEX6 AK9 ATP8B1 ABCA8 ABCB4 CCT8L2 DDX50 CLPB MOV10L1 ATP11A KIFC3 VCP DNHD1 DNAH10 DYNC2H1 ABCC6 ORC1 HELZ2 MACF1 CCT8L1P | 3.28e-05 | 614 | 231 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | cadherin binding | RPL24 TBC1D2 CDH23 EVPL ASAP1 PLEC VCL PUF60 RPL14 WASF2 MACF1 CTNND1 PLIN3 LRRFIP1 | 4.36e-05 | 339 | 231 | 14 | GO:0045296 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.70e-05 | 18 | 231 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | PEX6 AK9 ATP8B1 ABCA8 ABCB4 DDX50 CLPB MOV10L1 ATP11A VCP DNAH10 DYNC2H1 ABCC6 ORC1 HELZ2 MACF1 | 5.91e-05 | 441 | 231 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | phosphatase binding | MFHAS1 INSR CTTNBP2NL MAP3K5 PIK3R2 DLG4 VCP MTMR4 CDC5L CTNND1 CABIN1 AKAP1 | 6.20e-05 | 264 | 231 | 12 | GO:0019902 |
| GeneOntologyMolecularFunction | tRNA-specific adenosine deaminase activity | 8.20e-05 | 8 | 231 | 3 | GO:0008251 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | PEX6 AK9 ATP8B1 ABCA8 ABCB4 GUF1 DDX50 CLPB MOV10L1 ATP11A ATL2 GNG10 VCP DNAH10 DYNC2H1 ABCC6 RGS12 ATL1 ARL4D ORC1 HELZ2 MACF1 | 1.02e-04 | 775 | 231 | 22 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | PEX6 LHPP AK9 ATP8B1 ABCA8 ABCB4 GUF1 DDX50 CLPB MOV10L1 ATP11A ATL2 GNG10 VCP DNAH10 DYNC2H1 ABCC6 RGS12 ATL1 ARL4D ORC1 HELZ2 MACF1 | 1.19e-04 | 839 | 231 | 23 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | PEX6 LHPP AK9 ATP8B1 ABCA8 ABCB4 GUF1 DDX50 CLPB MOV10L1 ATP11A ATL2 GNG10 VCP DNAH10 DYNC2H1 ABCC6 RGS12 ATL1 ARL4D ORC1 HELZ2 MACF1 | 1.21e-04 | 840 | 231 | 23 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | PEX6 LHPP AK9 ATP8B1 ABCA8 ABCB4 GUF1 DDX50 CLPB MOV10L1 ATP11A ATL2 GNG10 VCP DNAH10 DYNC2H1 ABCC6 RGS12 ATL1 ARL4D ORC1 HELZ2 MACF1 | 1.21e-04 | 840 | 231 | 23 | GO:0016818 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.85e-04 | 46 | 231 | 5 | GO:0030020 | |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 2.88e-04 | 78 | 231 | 6 | GO:0003725 | |
| GeneOntologyMolecularFunction | adenosine deaminase activity | 4.01e-04 | 13 | 231 | 3 | GO:0004000 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TTLL5 SPTB MAEA TOGARAM1 SPTBN5 DST SUN2 DLG4 KIFC3 PLEC SETD3 VCL BICD2 CEP290 ESPNL DPYSL4 GRIA1 CCDC187 ANKRD23 CCDC88C WASF2 MACF1 CROCC AKAP1 MYBPC1 MYBPC2 | 4.34e-04 | 1099 | 231 | 26 | GO:0008092 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 6.16e-04 | 34 | 231 | 4 | GO:0016628 | |
| GeneOntologyMolecularFunction | floppase activity | 7.66e-04 | 16 | 231 | 3 | GO:0140328 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 7.69e-04 | 36 | 231 | 4 | GO:0019789 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 7.69e-04 | 36 | 231 | 4 | GO:0016814 | |
| GeneOntologyMolecularFunction | alanine-tRNA ligase activity | 7.87e-04 | 4 | 231 | 2 | GO:0004813 | |
| GeneOntologyMolecularFunction | histone H4K20 demethylase activity | 7.87e-04 | 4 | 231 | 2 | GO:0035575 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 8.54e-04 | 37 | 231 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor | 1.10e-03 | 18 | 231 | 3 | GO:0016646 | |
| GeneOntologyMolecularFunction | phosphatidylserine flippase activity | 1.30e-03 | 5 | 231 | 2 | GO:0140346 | |
| GeneOntologyMolecularFunction | histone H4 demethylase activity | 1.30e-03 | 5 | 231 | 2 | GO:0141058 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation antiporter activity | 1.30e-03 | 5 | 231 | 2 | GO:0140848 | |
| GeneOntologyMolecularFunction | histone H3K27me2/H3K27me3 demethylase activity | 1.30e-03 | 5 | 231 | 2 | GO:0071558 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 1.51e-03 | 20 | 231 | 3 | GO:0008525 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 2.07e-03 | 196 | 231 | 8 | GO:0005319 | |
| GeneOntologyCellularComponent | cell-cell junction | DCHS2 EPPK1 EVPL ABCB4 FAT1 DST JAG1 DLG4 KIFC3 VCL GRIA1 ANKRD23 CDC42BPB CLDN8 CCDC88C LIMS1 WASF2 CTNND1 | 9.67e-05 | 591 | 229 | 18 | GO:0005911 |
| GeneOntologyCellularComponent | anchoring junction | DCHS2 EPPK1 TBC1D2 EVPL ABCB4 FAT1 DST PIK3R2 JAG1 DLG4 KIFC3 PLEC VCL KLF11 GRIA1 ANKRD23 CDC42BPB CLDN8 CCDC88C LIMS1 TLE2 WASF2 CTNND1 RPL8 | 1.91e-04 | 976 | 229 | 24 | GO:0070161 |
| GeneOntologyCellularComponent | hemidesmosome | 2.01e-04 | 11 | 229 | 3 | GO:0030056 | |
| Domain | - | 1.54e-09 | 6 | 228 | 5 | 3.90.1290.10 | |
| Domain | Plectin | 5.34e-09 | 7 | 228 | 5 | PF00681 | |
| Domain | Plectin_repeat | 5.34e-09 | 7 | 228 | 5 | IPR001101 | |
| Domain | PLEC | 5.34e-09 | 7 | 228 | 5 | SM00250 | |
| Domain | Spectrin_repeat | 1.16e-06 | 29 | 228 | 6 | IPR002017 | |
| Domain | AAA | PEX6 AK9 ABCA8 ABCB4 CLPB VCP DNAH10 DYNC2H1 ABCC6 ORC1 HELZ2 | 1.59e-06 | 144 | 228 | 11 | SM00382 |
| Domain | AAA+_ATPase | PEX6 AK9 ABCA8 ABCB4 CLPB VCP DNAH10 DYNC2H1 ABCC6 ORC1 HELZ2 | 1.59e-06 | 144 | 228 | 11 | IPR003593 |
| Domain | SPEC | 2.15e-06 | 32 | 228 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.15e-06 | 32 | 228 | 6 | IPR018159 | |
| Domain | ACTININ_2 | 7.30e-06 | 23 | 228 | 5 | PS00020 | |
| Domain | ACTININ_1 | 7.30e-06 | 23 | 228 | 5 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 7.30e-06 | 23 | 228 | 5 | IPR001589 | |
| Domain | - | PPP1R12B ASAP1 GABPB2 CLPB ANKAR ANKDD1B ANKRD40 ANKK1 ESPNL ANKRD23 KANK2 ANKRD11 ANKRD24 | 1.19e-05 | 248 | 228 | 13 | 1.25.40.20 |
| Domain | ANK | PPP1R12B ASAP1 GABPB2 CLPB ANKAR ANKDD1B ANKRD40 ANKK1 ESPNL ANKRD23 KANK2 ANKRD11 ANKRD24 | 1.35e-05 | 251 | 228 | 13 | SM00248 |
| Domain | Ank_2 | PPP1R12B ASAP1 GABPB2 CLPB ANKAR ANKDD1B ANKK1 ESPNL ANKRD23 KANK2 ANKRD11 ANKRD24 | 1.39e-05 | 215 | 228 | 12 | PF12796 |
| Domain | ANK_REPEAT | PPP1R12B ASAP1 GABPB2 CLPB ANKAR ANKDD1B ANKRD40 ANKK1 ESPNL ANKRD23 KANK2 ANKRD11 ANKRD24 | 1.47e-05 | 253 | 228 | 13 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | PPP1R12B ASAP1 GABPB2 CLPB ANKAR ANKDD1B ANKRD40 ANKK1 ESPNL ANKRD23 KANK2 ANKRD11 ANKRD24 | 1.53e-05 | 254 | 228 | 13 | IPR020683 |
| Domain | ANK_REP_REGION | PPP1R12B ASAP1 GABPB2 CLPB ANKAR ANKDD1B ANKRD40 ANKK1 ESPNL ANKRD23 KANK2 ANKRD11 ANKRD24 | 1.53e-05 | 254 | 228 | 13 | PS50297 |
| Domain | Ankyrin_rpt | PPP1R12B ASAP1 GABPB2 CLPB ANKAR ANKDD1B ANKRD40 ANKK1 ESPNL ANKRD23 KANK2 ANKRD11 ANKRD24 | 2.13e-05 | 262 | 228 | 13 | IPR002110 |
| Domain | ADEAMc | 3.49e-05 | 6 | 228 | 3 | SM00552 | |
| Domain | A_deamin | 3.49e-05 | 6 | 228 | 3 | PF02137 | |
| Domain | A_DEAMIN_EDITASE | 3.49e-05 | 6 | 228 | 3 | PS50141 | |
| Domain | A_deamin | 3.49e-05 | 6 | 228 | 3 | IPR002466 | |
| Domain | VWA | 6.04e-05 | 56 | 228 | 6 | PF00092 | |
| Domain | DSRM | 7.26e-05 | 19 | 228 | 4 | SM00358 | |
| Domain | dsrm | 8.99e-05 | 20 | 228 | 4 | PF00035 | |
| Domain | DS_RBD | 1.10e-04 | 21 | 228 | 4 | PS50137 | |
| Domain | Ank | PPP1R12B ASAP1 GABPB2 CLPB ANKRD40 ANKK1 ESPNL ANKRD23 KANK2 ANKRD11 ANKRD24 | 1.18e-04 | 228 | 228 | 11 | PF00023 |
| Domain | ARM-like | SMG1 PSMD2 TOGARAM1 EFR3A ANKAR NCAPD2 MED12 TANGO6 ARMC6 HUWE1 SF3B1 CTNND1 | 1.26e-04 | 270 | 228 | 12 | IPR011989 |
| Domain | Ala_tRNA_ligase_euk/bac | 1.48e-04 | 2 | 228 | 2 | IPR023033 | |
| Domain | Ala-tRNA-ligase_IIc_anticod-bd | 1.48e-04 | 2 | 228 | 2 | IPR018162 | |
| Domain | Spectrin | 1.60e-04 | 23 | 228 | 4 | PF00435 | |
| Domain | TPR_REGION | 1.98e-04 | 165 | 228 | 9 | PS50293 | |
| Domain | TPR | 1.98e-04 | 165 | 228 | 9 | PS50005 | |
| Domain | Grip | 2.76e-04 | 11 | 228 | 3 | SM00755 | |
| Domain | GRIP | 2.76e-04 | 11 | 228 | 3 | PF01465 | |
| Domain | - | 2.87e-04 | 74 | 228 | 6 | 3.40.50.410 | |
| Domain | - | 3.04e-04 | 27 | 228 | 4 | 3.30.160.20 | |
| Domain | - | MFHAS1 PEX6 CHST6 AK9 ABCA8 ABCB4 GUF1 DDX50 CLPB MOV10L1 DLG4 ATL2 VCP DNHD1 DNAH10 DYNC2H1 ABCC6 ATL1 ARL4D ORC1 HELZ2 | 3.37e-04 | 746 | 228 | 21 | 3.40.50.300 |
| Domain | dsRBD_dom | 3.52e-04 | 28 | 228 | 4 | IPR014720 | |
| Domain | Ran_BP1 | 3.64e-04 | 12 | 228 | 3 | PF00638 | |
| Domain | RANBD1 | 3.64e-04 | 12 | 228 | 3 | PS50196 | |
| Domain | GRIP_dom | 3.64e-04 | 12 | 228 | 3 | IPR000237 | |
| Domain | GRIP | 3.64e-04 | 12 | 228 | 3 | PS50913 | |
| Domain | - | PSMD2 TOGARAM1 EFR3A ANKAR NCAPD2 MED12 TANGO6 ARMC6 SF3B1 CTNND1 | 4.15e-04 | 222 | 228 | 10 | 1.25.10.10 |
| Domain | Ala-tRNA-lgiase_IIc | 4.42e-04 | 3 | 228 | 2 | IPR002318 | |
| Domain | RanBD | 4.69e-04 | 13 | 228 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 4.69e-04 | 13 | 228 | 3 | IPR000156 | |
| Domain | VWFA | 5.01e-04 | 82 | 228 | 6 | PS50234 | |
| Domain | TPR-contain_dom | 5.19e-04 | 150 | 228 | 8 | IPR013026 | |
| Domain | VWA | 5.70e-04 | 84 | 228 | 6 | SM00327 | |
| Domain | Dynein_HC_stalk | 5.92e-04 | 14 | 228 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.92e-04 | 14 | 228 | 3 | IPR013602 | |
| Domain | DHC_N2 | 5.92e-04 | 14 | 228 | 3 | PF08393 | |
| Domain | MT | 5.92e-04 | 14 | 228 | 3 | PF12777 | |
| Domain | P-loop_NTPase | MFHAS1 PEX6 CHST6 AK9 ABCA8 ABCB4 GUF1 DDX50 CLPB MOV10L1 DLG4 KIFC3 ATL2 VCP DNHD1 DNAH10 DYNC2H1 ABCC6 ATL1 ARL4D ORC1 HELZ2 | 7.31e-04 | 848 | 228 | 22 | IPR027417 |
| Domain | DHC_fam | 7.33e-04 | 15 | 228 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 7.33e-04 | 15 | 228 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 7.33e-04 | 15 | 228 | 3 | IPR004273 | |
| Domain | TPR_1 | 8.22e-04 | 90 | 228 | 6 | IPR001440 | |
| Domain | TPR_1 | 8.22e-04 | 90 | 228 | 6 | PF00515 | |
| Domain | Ala-tRNA-synth_IIc_core | 8.76e-04 | 4 | 228 | 2 | IPR018165 | |
| Domain | Ala-tRNA-synth_IIc_N | 8.76e-04 | 4 | 228 | 2 | IPR018164 | |
| Domain | tRNA-synt_2c | 8.76e-04 | 4 | 228 | 2 | PF01411 | |
| Domain | AA_TRNA_LIGASE_II_ALA | 8.76e-04 | 4 | 228 | 2 | PS50860 | |
| Domain | ARM-type_fold | SMG1 INTS1 PSMD2 TOGARAM1 EFR3A ANKAR NCAPD2 TANGO6 ARMC6 HUWE1 SF3B1 CTNND1 | 9.80e-04 | 339 | 228 | 12 | IPR016024 |
| Domain | Translation_prot_SH3-like | 1.08e-03 | 17 | 228 | 3 | IPR008991 | |
| Domain | CH | 1.18e-03 | 65 | 228 | 5 | SM00033 | |
| Domain | VWF_A | 1.35e-03 | 99 | 228 | 6 | IPR002035 | |
| Domain | Sortilin_C | 1.45e-03 | 5 | 228 | 2 | PF15901 | |
| Domain | Sortilin-Vps10 | 1.45e-03 | 5 | 228 | 2 | PF15902 | |
| Domain | VPS10 | 1.45e-03 | 5 | 228 | 2 | IPR006581 | |
| Domain | Sortilin_N | 1.45e-03 | 5 | 228 | 2 | IPR031778 | |
| Domain | Sortilin_C | 1.45e-03 | 5 | 228 | 2 | IPR031777 | |
| Domain | Perilipin | 1.45e-03 | 5 | 228 | 2 | PF03036 | |
| Domain | VPS10 | 1.45e-03 | 5 | 228 | 2 | SM00602 | |
| Domain | Perilipin | 1.45e-03 | 5 | 228 | 2 | IPR004279 | |
| Domain | CH | 1.65e-03 | 70 | 228 | 5 | PF00307 | |
| Domain | - | 1.76e-03 | 71 | 228 | 5 | 1.10.418.10 | |
| Domain | CH | 1.99e-03 | 73 | 228 | 5 | PS50021 | |
| Domain | GAR | 2.15e-03 | 6 | 228 | 2 | PS51460 | |
| Domain | GAS2 | 2.15e-03 | 6 | 228 | 2 | PF02187 | |
| Domain | - | 2.15e-03 | 6 | 228 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 2.15e-03 | 6 | 228 | 2 | IPR003108 | |
| Domain | GAS2 | 2.15e-03 | 6 | 228 | 2 | SM00243 | |
| Domain | Cadherin_CS | 2.21e-03 | 109 | 228 | 6 | IPR020894 | |
| Domain | CH-domain | 2.24e-03 | 75 | 228 | 5 | IPR001715 | |
| Domain | PH_dom-like | TBC1D2 RGPD1 ASAP1 SPTBN5 FGD5 PREX1 RGPD5 RGPD8 CDC42BPB SH2B2 RGS12 GTF2H1 MTMR4 | 2.31e-03 | 426 | 228 | 13 | IPR011993 |
| Domain | CADHERIN_1 | 2.65e-03 | 113 | 228 | 6 | PS00232 | |
| Domain | Cadherin | 2.65e-03 | 113 | 228 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 2.76e-03 | 114 | 228 | 6 | PS50268 | |
| Domain | - | 2.76e-03 | 114 | 228 | 6 | 2.60.40.60 | |
| Domain | CA | 2.89e-03 | 115 | 228 | 6 | SM00112 | |
| Domain | tRNA_SAD | 2.99e-03 | 7 | 228 | 2 | IPR012947 | |
| Domain | Rab_bind | 2.99e-03 | 7 | 228 | 2 | PF16704 | |
| Domain | GCC2_Rab_bind | 2.99e-03 | 7 | 228 | 2 | IPR032023 | |
| Domain | tRNA_SAD | 2.99e-03 | 7 | 228 | 2 | SM00863 | |
| Domain | tRNA_SAD | 2.99e-03 | 7 | 228 | 2 | PF07973 | |
| Domain | JmjC | 3.01e-03 | 24 | 228 | 3 | PF02373 | |
| Domain | Cadherin-like | 3.01e-03 | 116 | 228 | 6 | IPR015919 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PDE2A EPPK1 MFHAS1 MAEA INTS1 PEX6 LHPP PIGG PTCH1 MAP3K5 FAT1 DST SH3TC1 NCAPD2 KIFC3 PLEC PREX1 MED12 WDR24 RHBDF2 PUF60 STK32C HUWE1 CDC42BPB SH2B2 WDR59 ORC1 CCDC88C RADIL ZNF827 HELZ2 ANKRD11 PC CABIN1 EVI5L | 2.53e-14 | 1105 | 233 | 35 | 35748872 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPL24 AARS1 ILF2 RPN1 PSMD2 PHF8 PFKM ADAR PHGDH ZBED5 ASAP1 GUF1 DST DDX50 WDR75 NCAPD2 HNRNPA0 DLAT PLEC MED12 VCL VCP RPP38 RPL14 HUWE1 WDR59 ORC1 GTF2H1 SF3B1 ZC2HC1A SLC25A13 NAT10 MACF1 CDC5L CTNND1 RPL8 | 1.76e-12 | 1353 | 233 | 36 | 29467282 |
| Pubmed | ILF2 EARS2 RPN1 TTLL5 PFKM SNAP47 EFR3A PNPT1 GUF1 WDR75 CLPB PIK3R2 SUN2 PEX19 HNRNPA0 DLAT VCL VCP PML DYNC2H1 C1orf43 RPL14 DZIP1 KANK2 CDC42BPB PREPL WDR19 SF3B1 NAT10 MRPS11 ANKRD11 MTR MACF1 CDC5L CTNND1 AKAP1 RPL8 | 5.91e-12 | 1487 | 233 | 37 | 33957083 | |
| Pubmed | DCHS2 AARS1 PDE2A TTLL5 SPTB PSMD2 ZBED5 GUF1 DST CLPB DLAT DLG4 KIFC3 PLEC PREX1 VCP BICD2 ZCCHC12 RBFOX3 CEP290 BIRC2 DZIP1 HUWE1 KANK2 CDC42BPB PREPL WDR59 WDR19 SF3B1 MACF1 ANKRD24 PC CABIN1 LRRFIP1 | 9.10e-12 | 1285 | 233 | 34 | 35914814 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | RPL24 ILF2 RPN1 PSMD2 ADAR PHGDH DDX50 HNRNPA0 VCP RPL14 HUWE1 SF3B1 NAT10 CDC5L RPL8 | 3.18e-11 | 221 | 233 | 15 | 29991511 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RPL24 ILF2 RPN1 TTC14 PSMD2 ADAR PHGDH DUS2 DDX50 WDR75 HNRNPA0 DLAT PLEC ATL2 VCL VCP PML RPL14 HUWE1 ORC1 GTF2H1 SF3B1 SLC25A13 NAT10 MRPS11 CDC5L CTNND1 PC RPL8 | 3.22e-11 | 989 | 233 | 29 | 36424410 |
| Pubmed | RPL24 RPN1 RGPD1 PSMD2 SNAP47 PHGDH ASAP1 PEX19 HNRNPA0 DLAT DLG4 PLEC VCP AKAP7 ARMC6 BICD2 RGPD8 GRIA1 RPL14 HUWE1 CDC42BPB ATL1 MICU3 SF3B1 MECR MACF1 CTNND1 PC RPL8 LRRFIP1 RBM17 | 4.11e-11 | 1139 | 233 | 31 | 36417873 | |
| Pubmed | AARS1 EPPK1 ILF2 INTS1 PSMD2 PNPT1 DST WDR75 NCAPD2 DLAT PLEC MED12 VCL VCP PUF60 RPL14 HUWE1 SF3B1 SLC25A13 NAT10 HELZ2 MACF1 RPL8 | 1.20e-10 | 653 | 233 | 23 | 22586326 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPL24 AARS1 ILF2 RPN1 PSMD2 PFKM ADAR PHGDH PHF2 DDX50 WDR75 CLPB NCAPD2 HNRNPA0 DLAT FGD5 ATL2 VCL DNHD1 DNAH10 DYNC2H1 PUF60 RPL14 HUWE1 SF3B1 SLC25A13 NAT10 MTR SCPEP1 CDC5L CTNND1 PC RPL8 MYBPC1 | 1.43e-10 | 1425 | 233 | 34 | 30948266 |
| Pubmed | TTC14 TOGARAM1 ABCA8 PHF2 AARS2 SUN2 ATP11A PREX1 MED12 TANGO6 DYNC2H1 CEP290 CDC42BPB WDR59 CCDC88C RADIL HELZ2 MACF1 ANKRD24 CDC5L | 1.79e-10 | 493 | 233 | 20 | 15368895 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RPL24 ILF2 RPN1 INTS1 ADAR PHGDH ZBED5 PHF2 PNPT1 DST DDX50 SUN2 HNRNPA0 PLEC MED12 VCP PUF60 DPYSL4 RPL14 SF3B1 ZC2HC1A SLC25A13 NAT10 HELZ2 MRPS11 MACF1 CDC5L RPL8 RBM17 | 2.64e-10 | 1082 | 233 | 29 | 38697112 |
| Pubmed | RPL24 ILF2 RPN1 MATN2 PPP1R12B INSR PSMD2 PFKM PHGDH PNPT1 PIK3R2 SUN2 HNRNPA0 DLAT MED12 VCL VCP PUF60 MED8 RPL14 HUWE1 SF3B1 ZC2HC1A WASF2 SLC25A13 NAT10 CDC5L CTNND1 PLIN3 RPL8 RBM17 | 3.78e-10 | 1247 | 233 | 31 | 27684187 | |
| Pubmed | PPP1R12B INTS1 PIGG CTTNBP2NL PHGDH EFR3A BLVRB PHF2 GUF1 DST DDX50 WDR75 CLPB SUN2 NCAPD2 TFB2M PREX1 MED12 MED8 RPP38 KANK2 CDC42BPB CEP164 ORC1 GTF2H1 WASF2 SLC25A13 SYNGR2 HELZ2 ANKRD11 MACF1 CROCC AKAP1 DGAT1 | 5.15e-10 | 1497 | 233 | 34 | 31527615 | |
| Pubmed | EARS2 MTHFD2 PEX6 PHF8 ABCA8 PHF2 FAT1 SALL2 SH3TC1 PIK3R2 SUN2 PCDH19 DLAT DLG4 VCP PML ARMC6 RPP38 BIRC2 C16orf96 KANK2 GTF2H1 ZNF827 SLC25A13 NAT10 MTR MACF1 EVI5L SORL1 | 5.37e-10 | 1116 | 233 | 29 | 31753913 | |
| Pubmed | RPL24 PDE2A ILF2 RPN1 PPP1R12B SPTB PSMD2 ALDH1L1 PFKM SNAP47 PHGDH ASAP1 DST HNRNPA0 DLAT DLG4 PLEC VCL VCP DPYSL4 GRIA1 RPL14 KANK2 CDC42BPB SF3B1 ZC2HC1A MACF1 CDC5L CTNND1 CROCC PC RPL8 LRRFIP1 | 6.50e-10 | 1431 | 233 | 33 | 37142655 | |
| Pubmed | AARS1 EPPK1 ILF2 EARS2 RPN1 PSMD2 PIGG PFKM ADAR PHGDH FAT1 DST DDX50 WDR75 HNRNPA0 ATP11A ECEL1 VCP ARMC6 RPP38 RPL14 KANK2 CDC42BPB MTMR4 SF3B1 SYNGR2 MRPS11 MACF1 CROCC AKAP1 RBM17 | 9.71e-10 | 1297 | 233 | 31 | 33545068 | |
| Pubmed | AARS1 EPPK1 TBC1D2 ADAR FAT1 DST WDR75 PEX19 PLEC VCP HUWE1 CDC42BPB WASF2 HELZ2 ANKRD11 MACF1 | 1.09e-09 | 332 | 233 | 16 | 37433992 | |
| Pubmed | SMG1 SPTB PHGDH ASAP1 MAP3K5 DST PLEC VCL VCP COL6A3 ANKRD23 DZIP1 CDC42BPB PREPL LIMS1 MACF1 AKAP1 MYBPC1 MYBPC2 | 1.39e-09 | 497 | 233 | 19 | 23414517 | |
| Pubmed | RPL24 AARS1 ILF2 RPN1 MTHFD2 MAEA PSMD2 PHGDH PNPT1 VNN2 NCAPD2 HNRNPA0 DLAT PLEC VCP PML PUF60 RPL14 CDC42BPB SF3B1 NAT10 CDC5L RPL8 LRRFIP1 | 1.44e-09 | 809 | 233 | 24 | 32129710 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RPL24 ILF2 EARS2 RPN1 MTHFD2 MAEA INTS1 RGPD1 PSMD2 PFKM PHGDH WDR75 CLPB HNRNPA0 TFB2M MED12 VCP RGPD5 ARMC6 ZCCHC12 RGPD8 RADX RPL14 HUWE1 SF3B1 SLC25A13 MTR CDC5L CTNND1 RPL8 | 1.92e-09 | 1257 | 233 | 30 | 37317656 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ILF2 EARS2 RPN1 MTHFD2 TTLL5 PEX6 PSMD2 PFKM SNAP47 SPTBN5 PNPT1 GUF1 DST DDX50 AARS2 WDR75 CLPB SUN2 PEX19 DLAT VCP RBFOX3 RGPD8 BIRC2 RPL14 HUWE1 PREPL ATL1 SLC25A13 NAT10 MRPS11 MTR AKAP1 | 1.97e-09 | 1496 | 233 | 33 | 32877691 |
| Pubmed | RPL24 AARS1 ILF2 RPN1 CTTNBP2NL DST DDX50 WDR75 HNRNPA0 PML COL6A3 RGPD8 CCDC88C SF3B1 TCP11L2 SLC25A13 CDC5L RPL8 RBM17 | 2.33e-09 | 513 | 233 | 19 | 25798074 | |
| Pubmed | RPL24 ILF2 RPN1 PSMD2 ADAR PHGDH AARS2 WDR75 NCAPD2 HNRNPA0 DLAT PLEC VCP PUF60 RPL14 HUWE1 SF3B1 SLC25A13 NAT10 CDC5L RPL8 | 2.65e-09 | 638 | 233 | 21 | 33239621 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RPL24 AARS1 PFKM GPKOW ADAR PHGDH DST DDX50 VCL VCP PML PUF60 DPYSL4 RPL14 SF3B1 WASF2 NAT10 MACF1 CDC5L CTNND1 PC AKAP1 PLIN3 RPL8 RBM17 | 5.07e-09 | 934 | 233 | 25 | 33916271 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | RPL24 EPPK1 ILF2 RPN1 MTHFD2 MATN2 PPP1R12B PSMD2 ADAR PHGDH DST DDX50 HNRNPA0 PLEC VCP PUF60 RPL14 SF3B1 SLC25A13 NAT10 CDC5L PC RPL8 LRRFIP1 RBM17 | 6.95e-09 | 949 | 233 | 25 | 36574265 |
| Pubmed | RPN1 PHF8 ADAR PHGDH NCAPD2 MED12 VCL RGPD5 PUF60 MED8 HUWE1 SLC25A13 NAT10 QSER1 CDC5L CTNND1 PC PLIN3 LRRFIP1 | 7.00e-09 | 549 | 233 | 19 | 38280479 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPPK1 ILF2 INSR INTS1 PSMD2 ADAR PHGDH DST DDX50 AARS2 WDR75 HNRNPA0 PLEC VCP PUF60 CEP290 RPL14 HUWE1 SF3B1 SLC25A13 NAT10 MACF1 CDC5L CTNND1 RPL8 RBM17 | 7.22e-09 | 1024 | 233 | 26 | 24711643 |
| Pubmed | AARS1 ILF2 MAEA PSMD2 ADAR PHGDH DLAT PLEC VCP PML RPP38 RPL14 HUWE1 CCDC88C SF3B1 NAT10 CDC5L RPL8 RBM17 | 7.42e-09 | 551 | 233 | 19 | 34728620 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RPL24 EPPK1 ILF2 RPN1 PSMD2 EVPL GPKOW ADAR PHGDH DST DDX50 WDR75 SUN2 HNRNPA0 TFB2M PLEC PML KRT4 PUF60 RPL14 GTF2H1 SF3B1 SLC25A13 NAT10 HELZ2 CDC5L CTNND1 RPL8 LRRFIP1 | 7.76e-09 | 1257 | 233 | 29 | 36526897 |
| Pubmed | SMG1 RPN1 MTHFD2 MAEA PSMD2 PIGG PFKM SNAP47 PHGDH DST DDX50 AARS2 CLPB SUN2 NCAPD2 PEX19 HNRNPA0 VCP PML RPL14 HUWE1 SF3B1 SLC25A13 NAT10 MRPS11 CDC5L CABIN1 PLIN3 LRRFIP1 EVI5L RBM17 | 1.12e-08 | 1440 | 233 | 31 | 30833792 | |
| Pubmed | SPTB EVPL GPKOW BLVRB DST AARS2 PLEC PML KRT4 CDC42BPB MACF1 CDC5L PC PLIN3 LRRFIP1 | 2.56e-08 | 360 | 233 | 15 | 33111431 | |
| Pubmed | AARS1 GPKOW SNAP47 PEX19 ATL2 VCL RGPD8 RADX CEP290 HUWE1 KANK2 WDR59 ATL1 MTMR4 MTR SCPEP1 QSER1 CDC5L CTNND1 CROCC AKAP1 | 2.92e-08 | 733 | 233 | 21 | 34672954 | |
| Pubmed | RPL24 AARS1 ILF2 ADAR PHGDH AARS2 HNRNPA0 PLEC PUF60 RPL14 KANK2 CDC42BPB SF3B1 SLC25A13 NAT10 MACF1 CTNND1 PC RPL8 | 2.96e-08 | 601 | 233 | 19 | 33658012 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | RPL24 SMG1 EPPK1 ILF2 ADAR PNPT1 DDX50 WDR75 HNRNPA0 TFB2M VCP PUF60 RADX RPL14 SF3B1 NAT10 HELZ2 MRPS11 MACF1 CDC5L AKAP1 RPL8 | 3.23e-08 | 807 | 233 | 22 | 22681889 |
| Pubmed | PDE2A ILF2 RGPD1 MAP3K5 DST DLG4 RGPD8 DPYSL4 GRIA1 HUWE1 KANK2 CDC42BPB PREPL CCDC88C SF3B1 ZC2HC1A WASF2 NAT10 MACF1 QSER1 CDC5L CTNND1 CABIN1 LRRFIP1 | 4.02e-08 | 963 | 233 | 24 | 28671696 | |
| Pubmed | RPN1 INTS1 PSMD2 ADAR PHF2 PLEC MED12 ANKK1 RPL14 SF3B1 NAT10 ANKRD11 RBM17 | 4.55e-08 | 272 | 233 | 13 | 31010829 | |
| Pubmed | SPTB SPTBN5 DST KIFC3 PLEC DNHD1 COL6A3 DNAH10 DYNC2H1 CROCC RPL8 | 6.22e-08 | 187 | 233 | 11 | 26460568 | |
| Pubmed | ADAR DST DDX50 PLEC UTY DNHD1 RGPD8 SF3B1 NAT10 MACF1 CDC5L PC | 7.03e-08 | 234 | 233 | 12 | 36243803 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RPL24 AARS1 EPPK1 ILF2 PSMD2 ADAR PHGDH SALL2 DST NCAPD2 PEX19 DLAT PLEC VCL VCP PUF60 RPL14 HUWE1 PREPL SF3B1 WASF2 MACF1 SCPEP1 CDC5L PLIN3 RPL8 | 7.18e-08 | 1149 | 233 | 26 | 35446349 |
| Pubmed | RPL24 AARS1 EPPK1 ILF2 RPN1 PSMD2 PHGDH WDR75 HNRNPA0 PLEC VCP PUF60 RPL14 SF3B1 SLC25A13 NAT10 MACF1 CTNND1 PLIN3 RPL8 | 8.49e-08 | 711 | 233 | 20 | 33022573 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RPL24 AARS1 EPPK1 ILF2 RPN1 PSMD2 PFKM PHGDH PNPT1 NCAPD2 HNRNPA0 DLAT TFB2M PLEC VCP KRT4 PUF60 RPL14 HUWE1 SF3B1 WASF2 SLC25A13 MACF1 CDC5L CTNND1 PC PLIN3 RPL8 LRRFIP1 | 9.92e-08 | 1415 | 233 | 29 | 28515276 |
| Pubmed | RPL24 ILF2 RPN1 PSMD2 PHGDH VCP PUF60 HUWE1 SF3B1 MTTP PC RPL8 | 1.11e-07 | 244 | 233 | 12 | 28902428 | |
| Pubmed | ILF2 RPN1 ADAR PHGDH HNRNPA0 VCP PUF60 RPL14 HUWE1 SF3B1 HELZ2 CDC5L CTNND1 RPL8 LRRFIP1 RBM17 | 1.36e-07 | 469 | 233 | 16 | 37314180 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | RPL24 AARS1 EPPK1 ILF2 RPN1 PSMD2 ALDH1L1 PHGDH GUF1 DST MOV10L1 PLEC VCL VCP DYNC2H1 PUF60 RPL14 HUWE1 MACF1 PC RPL8 | 1.46e-07 | 807 | 233 | 21 | 30575818 |
| Pubmed | SMG1 RPN1 PPP1R12B RGPD1 PSMD2 PFKM ABCB4 DST DDX50 WDR75 NCAPD2 HNRNPA0 DLAT ATP11A PLEC PREX1 RGPD5 RGPD8 PCDHGB3 PCDHGA10 MED8 GRIA1 RPL14 SF3B1 SLC25A13 MTTP MACF1 MYBPC1 MYBPC2 | 1.47e-07 | 1442 | 233 | 29 | 35575683 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | ILF2 RPN1 PHF8 PHGDH DDX50 PIK3R2 HNRNPA0 PUF60 RPL14 HUWE1 SF3B1 SLC25A13 NAT10 CDC5L PC RPL8 | 2.20e-07 | 486 | 233 | 16 | 30940648 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ILF2 RPN1 PHF8 ADAR PHGDH DDX50 DLAT MED12 WDR24 RADX RPP38 RPL14 SLC25A13 NAT10 MACF1 CDC5L AKAP1 RPL8 LRRFIP1 RBM17 | 2.40e-07 | 759 | 233 | 20 | 35915203 |
| Pubmed | RPL24 AARS1 ILF2 PSMD2 PFKM PHGDH HNRNPA0 PLEC VCL VCP RPL14 SF3B1 NAT10 CDC5L RPL8 LRRFIP1 | 2.74e-07 | 494 | 233 | 16 | 26831064 | |
| Pubmed | SMG1 TOGARAM1 PHF8 PHF2 SALL2 DST PREX1 CDC42BPB HELZ2 MACF1 CDC5L | 4.01e-07 | 225 | 233 | 11 | 12168954 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | RPL24 EPPK1 ILF2 RPN1 PSMD2 PFKM GPKOW PHGDH EFR3A HNRNPA0 PLEC RPL14 CDC42BPB NAT10 CTNND1 RPL8 MYBPC2 | 4.65e-07 | 580 | 233 | 17 | 35676659 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | EPPK1 INTS1 PSMD2 PFKM PHGDH NCAPD2 HNRNPA0 PLEC PUF60 HUWE1 LIMS1 SF3B1 NAT10 MACF1 CDC5L CTNND1 RBM17 | 4.87e-07 | 582 | 233 | 17 | 20467437 |
| Pubmed | RPL24 EPPK1 ILF2 RPN1 INTS1 PSMD2 EVPL ADAR DDX50 HNRNPA0 PLEC VCP PML RPL14 SF3B1 NAT10 CDC5L RPL8 | 5.04e-07 | 652 | 233 | 18 | 31180492 | |
| Pubmed | RPL24 ILF2 RPN1 MTHFD2 PHF8 PFKM ADAR PHGDH WDR75 HNRNPA0 TFB2M PREX1 BIRC2 RPL14 SF3B1 SLC25A13 MTR CDC5L RPL8 | 5.28e-07 | 725 | 233 | 19 | 27025967 | |
| Pubmed | RPL24 MTHFD2 PHGDH ASAP1 DDX50 SUN2 TFB2M PLEC PUF60 RPP38 RPL14 SF3B1 SLC25A13 NAT10 CDC5L CTNND1 PC RPL8 | 5.39e-07 | 655 | 233 | 18 | 35819319 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | AARS1 EPPK1 MTHFD2 PSMD2 PFKM GPKOW ADAR CTTNBP2NL PHGDH ASAP1 BLVRB AARS2 NCAPD2 ATL2 VCL VCP PUF60 DPYSL4 HUWE1 SF3B1 ZC2HC1A SYNGR2 MRPS11 PC PLIN3 LRRFIP1 RBM17 | 5.82e-07 | 1367 | 233 | 27 | 32687490 |
| Pubmed | EARS2 MTHFD2 SNAP47 AARS2 WDR75 SUN2 NCAPD2 ECEL1 TFB2M RBFOX3 DYNC2H1 RADX HUWE1 WDR59 MTR CTNND1 PC | 8.49e-07 | 606 | 233 | 17 | 36538041 | |
| Pubmed | RPL24 EPPK1 ILF2 RPN1 DDX50 HNRNPA0 PLEC RPL14 SF3B1 NAT10 RPL8 | 9.30e-07 | 245 | 233 | 11 | 21182205 | |
| Pubmed | EPPK1 ILF2 DHRS3 PSMD2 PHGDH PNPT1 CLPB FGD5 TFB2M TANGO6 DYNC2H1 POU3F1 KANK2 SF3B1 SLC25A13 NAT10 AKAP1 RPL8 RBM17 | 9.45e-07 | 754 | 233 | 19 | 35906200 | |
| Pubmed | RPL24 ILF2 RPN1 PSMD2 PHF8 PHGDH PHF2 DDX50 NCAPD2 HNRNPA0 VCP AKAP7 KRT4 PUF60 RADX RPP38 RPL14 SF3B1 SLC25A13 NAT10 MRPS11 MACF1 CDC5L RPL8 | 1.04e-06 | 1153 | 233 | 24 | 29845934 | |
| Pubmed | 1.18e-06 | 4 | 233 | 3 | 26926447 | ||
| Pubmed | Analysis of gene mutations in children with cholestasis of undefined etiology. | 1.18e-06 | 4 | 233 | 3 | 20683201 | |
| Pubmed | 1.18e-06 | 4 | 233 | 3 | 32665638 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | PDE2A RPN1 SPTB PSMD2 PFKM PHGDH ASAP1 PHF2 DST DLG4 VCP HUWE1 ATL1 SLC32A1 SLC25A13 PC RPL8 | 1.18e-06 | 621 | 233 | 17 | 22794259 |
| Pubmed | RPL24 AARS1 ILF2 RPN1 INTS1 PSMD2 PIGG ADAR DDX50 NCAPD2 ATP11A ATL2 MUL1 MED12 CEP290 RPL14 HUWE1 NAT10 HELZ2 APOL3 CDC5L AKAP1 PLIN3 RPL8 | 1.30e-06 | 1168 | 233 | 24 | 19946888 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | RPL24 SMG1 CDX2 ILF2 SPTB PSMD2 ADAR PHGDH DDX50 PLEC VCP RGPD5 RGPD8 RPL14 LIMS1 SLC25A13 RPL8 | 1.32e-06 | 626 | 233 | 17 | 33644029 |
| Pubmed | RPL24 SMG1 ILF2 RPN1 RGPD1 PSMD2 PHF8 PHF2 FAT1 SALL2 DST DDX50 DLAT VCL PML TANGO6 DNAH10 RADX MED8 RPL14 SLC25A13 NAT10 MRPS11 MTR QSER1 CABIN1 SORL1 | 1.35e-06 | 1429 | 233 | 27 | 35140242 | |
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | RPL24 ILF2 RPN1 ADAR PHGDH DLAT RPL14 HUWE1 SF3B1 RPL8 RBM17 | 1.43e-06 | 256 | 233 | 11 | 32698014 |
| Pubmed | 1.46e-06 | 160 | 233 | 9 | 31678930 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 1.58e-06 | 208 | 233 | 10 | 33230847 | |
| Pubmed | RPL24 AARS1 ILF2 RPN1 PSMD2 PHGDH PIK3R2 HNRNPA0 PLEC VCL VCP PUF60 RPL14 KANK2 SF3B1 NAT10 MACF1 RPL8 | 1.60e-06 | 707 | 233 | 18 | 19738201 | |
| Pubmed | RPL24 ILF2 RPN1 PSMD2 PHGDH EFR3A DST NCAPD2 MED12 VCL VCP RPL14 WASF2 SLC25A13 MACF1 CTNND1 PLIN3 RPL8 | 1.63e-06 | 708 | 233 | 18 | 39231216 | |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | EPPK1 PSMD2 ADAR CTTNBP2NL DST DDX50 VCP KANK2 HELZ2 MACF1 CDC5L CTNND1 | 1.67e-06 | 315 | 233 | 12 | 26777405 |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | RPL24 SMG1 EPPK1 ILF2 PPP1R12B CTTNBP2NL FAT1 ANKRD40 VCP PUF60 CEP290 RPL14 HUWE1 MRPS11 CTNND1 RPL8 SORL1 | 1.74e-06 | 639 | 233 | 17 | 23443559 |
| Pubmed | ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. | 1.98e-06 | 166 | 233 | 9 | 35687106 | |
| Pubmed | RPL24 ILF2 RPN1 MTHFD2 PSMD2 PHGDH SUN2 RPL14 SF3B1 SLC25A13 CDC5L RPL8 RBM17 | 2.21e-06 | 383 | 233 | 13 | 29331416 | |
| Pubmed | Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. | RPN1 MTHFD2 INSR PSMD2 ALDH1L1 PHGDH PREX1 VCP ARMC6 SF3B1 PLIN3 | 2.31e-06 | 269 | 233 | 11 | 30442662 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RPL24 ILF2 RPN1 INTS1 PHF8 ADAR PHF2 DST DDX50 WDR75 SUN2 HNRNPA0 CEP290 RPP38 RPL14 ORC1 SF3B1 NAT10 ANKRD11 QSER1 CDC5L PC CABIN1 RPL8 RBM17 | 2.32e-06 | 1294 | 233 | 25 | 30804502 |
| Pubmed | AARS1 RPN1 MFHAS1 PSMD2 AK9 PFKM ADAR DDX50 DLAT VCL VCP PUF60 RPL14 ZSCAN22 | 2.53e-06 | 451 | 233 | 14 | 36168627 | |
| Pubmed | ILF2 RPN1 PSMD2 ADAR PHGDH PHF2 HNRNPA0 VCP RPL14 HUWE1 SLC25A13 CDC5L | 2.96e-06 | 333 | 233 | 12 | 36779763 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | RPL24 ILF2 PSMD2 DDX50 SUN2 HNRNPA0 VCP PUF60 RPL14 SF3B1 SLC25A13 NAT10 MRPS11 QSER1 CDC5L CTNND1 RPL8 | 3.83e-06 | 678 | 233 | 17 | 30209976 |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | AARS1 EPPK1 ILF2 RPN1 MTHFD2 PSMD2 AARS2 CLPB VCL PUF60 CAMP RPL14 HUWE1 SLC25A13 CTNND1 PC | 3.97e-06 | 607 | 233 | 16 | 39147351 |
| Pubmed | RPL24 ILF2 RPN1 MAEA PSMD2 ADAR PHGDH WDR75 CLPB SUN2 HNRNPA0 DLAT TFB2M VCP PUF60 RPP38 RPL14 HUWE1 SF3B1 SLC25A13 MRPS11 CDC5L CTNND1 PC RPL8 | 4.00e-06 | 1335 | 233 | 25 | 29229926 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | RPN1 PSMD2 CTTNBP2NL WDR75 CLPB SUN2 PLEC VCP AKAP7 WDR24 RGPD5 BICD2 KRT4 DYNC2H1 HUWE1 PREPL WDR59 SLC25A13 SVIP CTNND1 AKAP1 | 4.79e-06 | 1005 | 233 | 21 | 19615732 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | RPL24 EPPK1 RPN1 PSMD2 DST DLAT PLEC VCL VCP RADX RPL14 HUWE1 SF3B1 LRRFIP1 | 4.82e-06 | 477 | 233 | 14 | 31300519 |
| Pubmed | RPL24 EPPK1 ILF2 RPN1 RGPD1 PSMD2 PHGDH DST CLPB PLEC VCP RGPD5 RGPD8 PUF60 SF3B1 SLC25A13 NAT10 MACF1 CTNND1 | 4.85e-06 | 844 | 233 | 19 | 25963833 | |
| Pubmed | IgSF21 promotes differentiation of inhibitory synapses via binding to neurexin2α. | 5.58e-06 | 18 | 233 | 4 | 28864826 | |
| Pubmed | Assessment of a polymorphism of SDK1 with hypertension in Japanese Individuals. | 5.58e-06 | 142 | 233 | 8 | 19851296 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RPL24 AARS1 ILF2 MAEA TBC1D2 PSMD2 PFKM CTTNBP2NL NCAPD2 HNRNPA0 PLEC ANKRD40 VCL VCP PUF60 RPP38 RPL14 HUWE1 WASF2 MTR MACF1 SCPEP1 CROCC PLIN3 RPL8 LRRFIP1 | 5.85e-06 | 1455 | 233 | 26 | 22863883 |
| Pubmed | 5.88e-06 | 241 | 233 | 10 | 23125841 | ||
| Pubmed | Association of genetic variants with hemorrhagic stroke in Japanese individuals. | 5.88e-06 | 143 | 233 | 8 | 20198315 | |
| Pubmed | RPL24 RPN1 MTHFD2 PSMD2 DLAT PLEC VCL VCP PUF60 RPL14 SF3B1 MACF1 CTNND1 RPL8 | 6.24e-06 | 488 | 233 | 14 | 31324722 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | GSDMB CDH23 TOGARAM1 CYP46A1 FAT1 DDX50 HNRNPA0 WDR24 KANK2 MICU3 SF3B1 MACF1 | 6.72e-06 | 361 | 233 | 12 | 26167880 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | RPL24 EVPL ASAP1 EFR3A DST PLEC VCL PUF60 RPL14 KANK2 WASF2 MACF1 CTNND1 PLIN3 LRRFIP1 | 7.35e-06 | 565 | 233 | 15 | 25468996 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DCHS2 AARS1 AK9 ALDH1L1 CROCC2 NCAPD2 MED12 COL6A6 CCDC187 RGS12 NSUN7 SLC25A13 ANKRD11 CTNND1 | 7.67e-06 | 497 | 233 | 14 | 36774506 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DHRS3 SPTB MAEA INSR TTC14 LHPP ATP8B1 PHF2 SLC41A3 SH3TC1 ANKAR ATP11A RHBDF2 STK32C HUWE1 CDC42BPB CEP43 ZNF827 NAT10 ANKRD11 MACF1 ANKRD24 QSER1 CTNND1 CROCC EVI5L | 8.78e-06 | 1489 | 233 | 26 | 28611215 |
| Pubmed | 9.23e-06 | 109 | 233 | 7 | 29511296 | ||
| Pubmed | Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context. | EARS2 MTHFD2 ISCA2 ALDH1L1 ADAR DUS2 CKMT2 PNPT1 GUF1 AARS2 CLPB DLAT TFB2M KIFC3 MUL1 PREPL MICU3 MECR SLC25A13 MRPS11 PC AKAP1 | 9.34e-06 | 1136 | 233 | 22 | 34800366 |
| Pubmed | ILF2 RPN1 PSMD2 ADAR PHGDH PNPT1 DDX50 CLPB VCP ARMC6 PUF60 RPL14 SF3B1 NAT10 CDC5L RBM17 | 9.89e-06 | 653 | 233 | 16 | 33742100 | |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | EPPK1 RPN1 PSMD2 PFKM PHGDH CKMT2 PUF60 RPL14 HUWE1 SLC25A13 | 9.97e-06 | 256 | 233 | 10 | 35777956 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RPL24 ILF2 RPN1 INTS1 PSMD2 ADAR BLVRB PHF2 GUF1 DDX50 WDR75 HNRNPA0 PLEC ARMC6 PUF60 RPL14 HUWE1 SF3B1 SLC25A13 NAT10 MRPS11 CDC5L PC RPL8 | 1.00e-05 | 1318 | 233 | 24 | 30463901 |
| Interaction | TOP3B interactions | PDE2A EPPK1 MFHAS1 SPTB MAEA INTS1 PEX6 LHPP PIGG PTCH1 PHGDH MAP3K5 FAT1 DST SH3TC1 NCAPD2 HNRNPA0 DLAT KIFC3 PLEC PREX1 MED12 WDR24 RHBDF2 PUF60 STK32C HUWE1 KANK2 CDC42BPB SH2B2 WDR59 ORC1 CCDC88C RADIL ZNF827 SLC25A13 HELZ2 ANKRD11 PC CABIN1 EVI5L | 9.34e-08 | 1470 | 231 | 41 | int:TOP3B |
| Interaction | OBSL1 interactions | EPPK1 ILF2 RPN1 MAEA PSMD2 PHF8 ADAR PHGDH DST MYLK3 DDX50 WDR75 CROCC2 HNRNPA0 DLAT PLEC VCP PUF60 RPL14 HUWE1 KANK2 MTMR4 SF3B1 NAT10 MACF1 CDC5L RPL8 RBM17 | 1.72e-06 | 902 | 231 | 28 | int:OBSL1 |
| Interaction | MEX3A interactions | AARS1 CDX2 EPPK1 TBC1D2 ADAR FAT1 DST WDR75 PEX19 PLEC VCP HUWE1 CDC42BPB WASF2 HELZ2 ANKRD11 MACF1 | 2.31e-06 | 384 | 231 | 17 | int:MEX3A |
| Interaction | KCNA3 interactions | RPL24 EPPK1 ILF2 RPN1 PSMD2 PFKM PHGDH EFR3A DST NCAPD2 DLG4 MED12 VCL VCP DNHD1 PUF60 MED8 RPL14 ORC1 CCDC88C WASF2 SLC25A13 MACF1 CTNND1 PLIN3 RPL8 SORL1 | 2.74e-06 | 871 | 231 | 27 | int:KCNA3 |
| Interaction | NEK4 interactions | RPL24 AARS1 ILF2 RPN1 CTTNBP2NL DST DDX50 WDR75 CLPB HNRNPA0 PML COL6A3 RGPD8 CCDC88C SF3B1 TCP11L2 SLC25A13 MTR CDC5L RPL8 RBM17 | 3.85e-06 | 582 | 231 | 21 | int:NEK4 |
| Interaction | RPA4 interactions | RPL24 RPN1 PFKM GPKOW SALL2 DST HNRNPA0 SETD3 PREX1 VCP BICD2 RPL14 SF3B1 NAT10 CDC5L AKAP1 RPL8 RBM17 | 5.10e-06 | 452 | 231 | 18 | int:RPA4 |
| Interaction | SIRT7 interactions | AARS1 EPPK1 ILF2 INTS1 PSMD2 PNPT1 DST WDR75 NCAPD2 DLAT PLEC MED12 VCL VCP PUF60 RPL14 HUWE1 SF3B1 WASF2 SLC25A13 NAT10 HELZ2 MACF1 RPL8 | 5.24e-06 | 744 | 231 | 24 | int:SIRT7 |
| Interaction | KIF20A interactions | RPL24 EPPK1 ILF2 SPTB MAEA ADAR PHGDH EFR3A DDX50 WDR75 HNRNPA0 KIFC3 PLEC VCP PML RBFOX3 RGPD8 DYNC2H1 PUF60 RPL14 CDC42BPB RGS12 SF3B1 P2RY11 NAT10 MACF1 CTNND1 RPL8 RBM17 | 1.11e-05 | 1052 | 231 | 29 | int:KIF20A |
| Interaction | KRT14 interactions | 1.41e-05 | 192 | 231 | 11 | int:KRT14 | |
| Interaction | RANBP2 interactions | ILF2 RGPD1 ADAR VCP PML RGPD5 BICD2 RGPD8 RHBDF2 STK32C HUWE1 SF3B1 CDC5L MYBPC2 RBM17 | 1.95e-05 | 361 | 231 | 15 | int:RANBP2 |
| Interaction | PRC1 interactions | RPL24 AARS1 EPPK1 ILF2 RPN1 SPTB MAEA PSMD2 PFKM ADAR DDX50 WDR75 HNRNPA0 PLEC VCL VCP BICD2 PUF60 RPL14 RGS12 SF3B1 SLC25A13 NAT10 CDC5L RPL8 MYBPC1 RBM17 | 2.03e-05 | 973 | 231 | 27 | int:PRC1 |
| Interaction | UBXN6 interactions | PSMD2 PFKM MAP3K5 CCT8L2 DST PIK3R2 NCAPD2 VCP TANGO6 RGPD5 RGPD8 ARL4D MTR SVIP | 2.49e-05 | 325 | 231 | 14 | int:UBXN6 |
| Interaction | PRMT1 interactions | RPL24 AARS1 ILF2 MAEA PSMD2 PTCH1 ADAR PHGDH MAP3K5 NCAPD2 DLAT FGD5 PLEC VCP PML ZCCHC12 RPP38 RPL14 HUWE1 CCDC88C SF3B1 NAT10 CDC5L RPL8 LRRFIP1 RBM17 | 2.53e-05 | 929 | 231 | 26 | int:PRMT1 |
| Interaction | NPAS1 interactions | INTS1 PEX6 ADAR NCAPD2 RGPD5 RGPD8 KANK2 WDR59 ANKRD11 MTR QSER1 AKAP1 | 2.75e-05 | 245 | 231 | 12 | int:NPAS1 |
| Interaction | ECT2 interactions | RPL24 EPPK1 ILF2 RPN1 SPTB MAEA PIGG PHGDH DST DDX50 NCAPD2 HNRNPA0 KIFC3 PLEC PML PUF60 RPL14 WDR59 CEP164 SF3B1 NAT10 MACF1 CDC5L RPL8 RBM17 | 3.26e-05 | 887 | 231 | 25 | int:ECT2 |
| Interaction | SQSTM1 interactions | SMG1 AARS1 ILF2 EARS2 INSR PSMD2 PFKM ANGPTL8 ADAR PHGDH WDR75 CLPB PIK3R2 HNRNPA0 VCP PML CEP290 RPP38 BIRC2 GRIA1 STK32C HUWE1 CEP43 CEP164 CCDC88C MTMR4 SYNGR2 MRPS11 MTR CTNND1 CROCC | 4.66e-05 | 1257 | 231 | 31 | int:SQSTM1 |
| Interaction | GRWD1 interactions | RPL24 ILF2 RPN1 PSMD2 ADAR PHGDH DDX50 HNRNPA0 VCP RPL14 HUWE1 SF3B1 NAT10 CDC5L RPL8 | 4.73e-05 | 390 | 231 | 15 | int:GRWD1 |
| Interaction | CLK1 interactions | MFHAS1 GSDMB CDH23 ADAR CYP46A1 FAT1 HNRNPA0 SH2B2 MICU3 GTF2H1 SF3B1 | 4.73e-05 | 219 | 231 | 11 | int:CLK1 |
| Interaction | KCTD13 interactions | RPL24 PDE2A ILF2 RPN1 PPP1R12B SPTB PSMD2 ALDH1L1 PFKM SNAP47 PHGDH ASAP1 DST HNRNPA0 DLAT DLG4 PLEC VCL VCP DPYSL4 GRIA1 RPL14 KANK2 CDC42BPB SF3B1 ZC2HC1A MACF1 CDC5L CTNND1 CROCC PC RPL8 LRRFIP1 | 5.78e-05 | 1394 | 231 | 33 | int:KCTD13 |
| Interaction | BIRC3 interactions | RPL24 AARS1 ILF2 RPN1 PFKM ADAR PHGDH PHF2 DDX50 WDR75 CLPB NCAPD2 HNRNPA0 DLAT ATL2 VCL DNHD1 DNAH10 DYNC2H1 PUF60 BIRC2 RPL14 HUWE1 SF3B1 SLC25A13 NAT10 SCPEP1 CDC5L CTNND1 PC RPL8 MYBPC1 | 5.90e-05 | 1334 | 231 | 32 | int:BIRC3 |
| Interaction | TNIP1 interactions | RPL24 AARS1 EPPK1 ILF2 RPN1 MTHFD2 MATN2 PPP1R12B PSMD2 ADAR PHGDH DST DDX50 HNRNPA0 KIFC3 PLEC VCP PUF60 BIRC2 RPL14 GTF2H1 SF3B1 SLC25A13 NAT10 CDC5L PC CFAP53 RPL8 LRRFIP1 RBM17 | 6.30e-05 | 1217 | 231 | 30 | int:TNIP1 |
| Interaction | HECTD1 interactions | ILF2 RPN1 PSMD2 PHF8 ADAR PHGDH DDX50 SUN2 NCAPD2 DLAT MED12 VCP WDR24 RADX RPP38 RPL14 HUWE1 SLC25A13 NAT10 ANKRD11 MACF1 CDC5L AKAP1 RPL8 LRRFIP1 RBM17 | 6.61e-05 | 984 | 231 | 26 | int:HECTD1 |
| Interaction | AURKB interactions | AARS1 EPPK1 MFHAS1 MAEA PSMD2 PFKM PNPT1 DDX50 CLPB NCAPD2 KIFC3 PLEC VCP RPL14 HUWE1 SF3B1 SLC25A13 NAT10 MACF1 CDC5L AKAP1 RPL8 | 6.86e-05 | 761 | 231 | 22 | int:AURKB |
| Interaction | C9orf72 interactions | RPL24 ILF2 EARS2 RPN1 MTHFD2 MAEA INTS1 RGPD1 PSMD2 PFKM PHGDH WDR75 CLPB HNRNPA0 TFB2M MED12 VCL VCP RGPD5 ARMC6 ZCCHC12 RGPD8 RADX RPL14 HUWE1 SF3B1 SLC25A13 MTR CDC5L CTNND1 RPL8 | 1.13e-04 | 1319 | 231 | 31 | int:C9orf72 |
| Interaction | ARMC5 interactions | 1.13e-04 | 201 | 231 | 10 | int:ARMC5 | |
| Interaction | RGPD5 interactions | 1.19e-04 | 96 | 231 | 7 | int:RGPD5 | |
| Interaction | CIT interactions | RPL24 AARS1 EPPK1 ILF2 RPN1 SPTB INTS1 PSMD2 PFKM ADAR PHGDH MAP3K5 PHF2 DDX50 WDR75 CLPB HNRNPA0 DLG4 TFB2M PLEC DYNC2H1 PUF60 RPL14 MTMR4 SF3B1 SLC25A13 NAT10 MACF1 CDC5L CTNND1 CFAP53 RPL8 RBM17 | 1.22e-04 | 1450 | 231 | 33 | int:CIT |
| Interaction | KIF23 interactions | RPL24 CDX2 EPPK1 ILF2 RPN1 MATN2 PSMD2 AK9 PFKM ADAR PHGDH EFR3A DDX50 WDR75 DLAT KIFC3 PLEC PUF60 RPL14 HUWE1 SLC32A1 SF3B1 NAT10 MACF1 RPL8 RBM17 | 1.40e-04 | 1031 | 231 | 26 | int:KIF23 |
| Interaction | NAA40 interactions | RPL24 AARS1 PFKM GPKOW ADAR PHGDH DST DDX50 VCL VCP PML PUF60 DPYSL4 RPL14 SF3B1 WASF2 NAT10 MACF1 CDC5L CTNND1 PC AKAP1 PLIN3 RPL8 RBM17 | 1.54e-04 | 978 | 231 | 25 | int:NAA40 |
| Interaction | NRIP1 interactions | 1.56e-04 | 170 | 231 | 9 | int:NRIP1 | |
| Interaction | GAN interactions | SPTB SPTBN5 DST KIFC3 PLEC DNHD1 COL6A3 DNAH10 DYNC2H1 CROCC RPL8 | 1.71e-04 | 253 | 231 | 11 | int:GAN |
| Interaction | PAGE4 interactions | RPL24 ILF2 RPN1 ADAR PHGDH DLAT RPL14 HUWE1 SF3B1 RPL8 RBM17 | 1.71e-04 | 253 | 231 | 11 | int:PAGE4 |
| Interaction | LATS1 interactions | RGPD1 CKMT2 DDX50 SUN2 DLAT PLEC KRT4 CEP290 BIRC2 CCDC88C SF3B1 SLC25A13 MYBPC1 MYBPC2 RBM17 | 1.80e-04 | 440 | 231 | 15 | int:LATS1 |
| Interaction | GPR45 interactions | EARS2 INTS1 PEX6 PIGG EFR3A GUF1 PEX19 TFB2M ATL2 ARMC6 SYNGR2 EVI5L | 1.89e-04 | 300 | 231 | 12 | int:GPR45 |
| GeneFamily | EF-hand domain containing|Plakins | 2.38e-09 | 8 | 155 | 5 | 939 | |
| GeneFamily | Ankyrin repeat domain containing | PPP1R12B ASAP1 GABPB2 CLPB ANKAR ANKDD1B ANKRD40 ANKK1 ESPNL ANKRD23 KANK2 ANKRD11 ANKRD24 | 1.70e-07 | 242 | 155 | 13 | 403 |
| GeneFamily | Adenosine deaminases acting on RNA | 3.35e-05 | 8 | 155 | 3 | 1303 | |
| GeneFamily | Collagens | 4.48e-05 | 46 | 155 | 5 | 490 | |
| GeneFamily | Cadherin related | 3.85e-04 | 17 | 155 | 3 | 24 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 4.70e-04 | 115 | 155 | 6 | 769 | |
| GeneFamily | Perilipins | 7.18e-04 | 5 | 155 | 2 | 678 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 1.10e-03 | 24 | 155 | 3 | 485 | |
| GeneFamily | AAA ATPases | 1.10e-03 | 53 | 155 | 4 | 413 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.49e-03 | 7 | 155 | 2 | 1113 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 1.98e-03 | 8 | 155 | 2 | 658 | |
| GeneFamily | Fibronectin type III domain containing | 2.59e-03 | 160 | 155 | 6 | 555 | |
| GeneFamily | UPF1 like RNA helicases | 3.82e-03 | 11 | 155 | 2 | 1169 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.93e-03 | 43 | 155 | 3 | 409 | |
| Coexpression | GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN | RPL24 PHGDH PNPT1 SH3TC1 CAMP ODC1 SLC32A1 MICU3 GTF2H1 MECR ANKRD11 | 1.92e-06 | 200 | 233 | 11 | M5806 |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL | 2.26e-06 | 164 | 233 | 10 | M41676 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN | EPPK1 MAP3K5 CPQ DLG4 RADX CCDC88C APOL3 SORCS3 SCPEP1 SORL1 | 1.25e-05 | 199 | 233 | 10 | M3476 |
| Coexpression | CAMP_UP.V1_UP | 1.31e-05 | 200 | 233 | 10 | M2720 | |
| Coexpression | TRAVAGLINI_LUNG_CILIATED_CELL | EPPK1 TTLL5 PEX6 CHST6 ISCA2 AK9 COL21A1 XRRA1 DNAH10 DYNC2H1 CEP290 RPP38 DZIP1 CEP43 CLDN8 CEP164 NSUN7 WDR19 CCDC88C ZC2HC1A SCPEP1 CROCC CABIN1 CFAP53 PLIN3 | 1.59e-05 | 1093 | 233 | 25 | M41649 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | RPN1 MATN2 ASAP1 SUN2 PCDH19 VCL VCP PUF60 BIRC2 THBS3 ANKRD11 SCPEP1 AKAP1 RPL8 DGAT1 | 1.63e-05 | 457 | 233 | 15 | M1613 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | RPN1 MATN2 ASAP1 SUN2 PCDH19 VCL VCP PUF60 BIRC2 THBS3 ANKRD11 SCPEP1 AKAP1 RPL8 DGAT1 | 2.26e-05 | 470 | 233 | 15 | MM1053 |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 3.40e-05 | 179 | 233 | 9 | M39308 | |
| Coexpression | NABA_COLLAGENS | 4.35e-05 | 44 | 233 | 5 | M3005 | |
| Coexpression | EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION | 6.67e-05 | 48 | 233 | 5 | M16123 | |
| Coexpression | GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 7.44e-05 | 198 | 233 | 9 | M9163 | |
| Coexpression | GSE13306_RA_VS_UNTREATED_TREG_UP | 8.04e-05 | 200 | 233 | 9 | M3232 | |
| Coexpression | GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN | 8.04e-05 | 200 | 233 | 9 | M6533 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | MATN2 PPP1R12B PTCH1 FAT1 DST COL6A3 DZIP1 KANK2 ATL1 ZC2HC1A ROBO2 | 8.86e-09 | 199 | 233 | 11 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.04e-07 | 199 | 233 | 10 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | MATN2 PPP1R12B PTCH1 FAT1 VCL COL6A3 DZIP1 KANK2 ZC2HC1A ROBO2 | 1.09e-07 | 200 | 233 | 10 | 87827041663013f5e7273168dc8709d69840e7ce |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | MATN2 PPP1R12B PTCH1 ANGPTL8 FAT1 COL6A3 DZIP1 KANK2 ZC2HC1A ROBO2 | 1.09e-07 | 200 | 233 | 10 | a9ff3210127000b3dd9e97136163c98c2b0817d7 |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | PPP1R12B PTCH1 FAT1 DST VCL COL6A3 DZIP1 KANK2 ZC2HC1A ROBO2 | 1.09e-07 | 200 | 233 | 10 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | AK9 COL21A1 CROCC2 DNAH10 DYNC2H1 NSUN7 CCDC88C CROCC CFAP53 | 2.79e-07 | 169 | 233 | 9 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f |
| ToppCell | HSPCs-Erythroblasts|HSPCs / Lineage and Cell class | 4.98e-07 | 181 | 233 | 9 | 4ded490f190af7ace343acdf317edc7373484d08 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 6.55e-07 | 187 | 233 | 9 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.81e-07 | 191 | 233 | 9 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.16e-07 | 192 | 233 | 9 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 8.16e-07 | 192 | 233 | 9 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.90e-07 | 194 | 233 | 9 | fb80a0271ccb1cb3f954ebcf2c5945cb6adb6b8c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.90e-07 | 194 | 233 | 9 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.90e-07 | 194 | 233 | 9 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.28e-07 | 195 | 233 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 9.28e-07 | 195 | 233 | 9 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.28e-07 | 195 | 233 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.69e-07 | 196 | 233 | 9 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.01e-06 | 197 | 233 | 9 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 1.01e-06 | 197 | 233 | 9 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-06 | 197 | 233 | 9 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.01e-06 | 197 | 233 | 9 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.10e-06 | 199 | 233 | 9 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.10e-06 | 199 | 233 | 9 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.15e-06 | 200 | 233 | 9 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 1.15e-06 | 200 | 233 | 9 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.15e-06 | 200 | 233 | 9 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.15e-06 | 200 | 233 | 9 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.15e-06 | 200 | 233 | 9 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.15e-06 | 200 | 233 | 9 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.15e-06 | 200 | 233 | 9 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.15e-06 | 200 | 233 | 9 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.13e-06 | 169 | 233 | 8 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.99e-06 | 180 | 233 | 8 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.99e-06 | 180 | 233 | 8 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | HSPCs-Erythroblasts|World / Lineage and Cell class | 5.19e-06 | 181 | 233 | 8 | ce26f1accc8f69b7bc4b929073e975c887566c6a | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-06 | 182 | 233 | 8 | edfc598b7199ca1d8a399b264ab863c299b1eede | |
| ToppCell | Nasal_Brush-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.34e-06 | 186 | 233 | 8 | f5aa91dbef29f7efa2b9a728c6539d7541340cd4 | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-06 | 189 | 233 | 8 | 98ace332c3c046694c6ade47de8c8bf57ec51271 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.31e-06 | 193 | 233 | 8 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.31e-06 | 193 | 233 | 8 | 49f4fbec91acda4727703e0e359ed780eefb8a22 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 8.31e-06 | 193 | 233 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.63e-06 | 194 | 233 | 8 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 8.96e-06 | 195 | 233 | 8 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.96e-06 | 195 | 233 | 8 | c5d2d9f12fd893331c9de261af30607d845d4f6a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.96e-06 | 195 | 233 | 8 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 8.96e-06 | 195 | 233 | 8 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.30e-06 | 196 | 233 | 8 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.30e-06 | 196 | 233 | 8 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 9.30e-06 | 196 | 233 | 8 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.30e-06 | 196 | 233 | 8 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.65e-06 | 197 | 233 | 8 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.65e-06 | 197 | 233 | 8 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.65e-06 | 197 | 233 | 8 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.65e-06 | 197 | 233 | 8 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | 11.5-Airway-Mesenchymal|Airway / Age, Tissue, Lineage and Cell class | 1.00e-05 | 198 | 233 | 8 | fe08709d043d927988b1bb262c766b0b572fc927 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.00e-05 | 198 | 233 | 8 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.00e-05 | 198 | 233 | 8 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.00e-05 | 198 | 233 | 8 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.04e-05 | 199 | 233 | 8 | fb23ecce41e31e2cc01814e3c0add756f489561f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-05 | 199 | 233 | 8 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 199 | 233 | 8 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 199 | 233 | 8 | 079931e7196719f22a89cfad82f452ec67219ee5 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-05 | 199 | 233 | 8 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.04e-05 | 199 | 233 | 8 | 655d07cf9a2fd9b945a2ed4f824cba0297de72a8 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.08e-05 | 200 | 233 | 8 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.08e-05 | 200 | 233 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.08e-05 | 200 | 233 | 8 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.08e-05 | 200 | 233 | 8 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.08e-05 | 200 | 233 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.08e-05 | 200 | 233 | 8 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-05 | 200 | 233 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.08e-05 | 200 | 233 | 8 | 76f3043cb88071256ff661885fe5a82a54f5b733 | |
| ToppCell | distal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.08e-05 | 200 | 233 | 8 | 20112be28f80baffad92641c9cfd7c3718967dbb | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-05 | 200 | 233 | 8 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.08e-05 | 200 | 233 | 8 | 64d2941689d7ca8af54f9ba21c5aeabf719084ef | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.08e-05 | 200 | 233 | 8 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.08e-05 | 200 | 233 | 8 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-05 | 200 | 233 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.08e-05 | 200 | 233 | 8 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-05 | 155 | 233 | 7 | 4559e3011514041b65c17ae4ede29da202bce14c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-05 | 158 | 233 | 7 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 159 | 233 | 7 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 159 | 233 | 7 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-05 | 162 | 233 | 7 | 860ebf2390b4ad86475ad54717cbefcf61cd3b2a | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-05 | 162 | 233 | 7 | 14e9f8aaba308619eb9da90796c336e76cedac1f | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.86e-05 | 167 | 233 | 7 | 5c82d801e3b7d7c6c967a73b94b2ee2a8da1fd6e | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-05 | 167 | 233 | 7 | 961e722442d786ab15d1e490941d2be265a9057a | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-05 | 167 | 233 | 7 | 3760efc35d4e7e9c2da1a20f9795ddea397e2206 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-05 | 168 | 233 | 7 | b9db0b1e4fe54a1fe79530d15d206155a1bfac39 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.09e-05 | 169 | 233 | 7 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.59e-05 | 173 | 233 | 7 | ab6d3507301038f944ad59ccd848b5e6eeb76d04 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.86e-05 | 175 | 233 | 7 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.86e-05 | 175 | 233 | 7 | 085cceb1fc2c4ae2f27e85cea5702defecc2cf44 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.15e-05 | 177 | 233 | 7 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.15e-05 | 177 | 233 | 7 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.78e-05 | 181 | 233 | 7 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-05 | 182 | 233 | 7 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-05 | 182 | 233 | 7 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-05 | 182 | 233 | 7 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| Computational | Genes in the cancer module 272. | 1.53e-05 | 12 | 147 | 4 | MODULE_272 | |
| Disease | syndromic X-linked intellectual disability (implicated_via_orthology) | 2.48e-05 | 8 | 228 | 3 | DOID:0060309 (implicated_via_orthology) | |
| Disease | Lambert-Eaton Myasthenic Syndrome | 5.94e-05 | 2 | 228 | 2 | C0022972 | |
| Disease | dermatomyositis (implicated_via_orthology) | 5.94e-05 | 2 | 228 | 2 | DOID:10223 (implicated_via_orthology) | |
| Disease | Myasthenic Syndrome | 5.94e-05 | 2 | 228 | 2 | C0549225 | |
| Disease | axonal neuropathy (implicated_via_orthology) | 5.94e-05 | 2 | 228 | 2 | DOID:7319 (implicated_via_orthology) | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 9.51e-05 | 12 | 228 | 3 | C0403553 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 1.09e-04 | 239 | 228 | 9 | EFO_0010934 | |
| Disease | Progressive intrahepatic cholestasis (disorder) | 1.77e-04 | 3 | 228 | 2 | C0268312 | |
| Disease | hereditary spastic paraplegia 3A (implicated_via_orthology) | 1.77e-04 | 3 | 228 | 2 | DOID:0110791 (implicated_via_orthology) | |
| Disease | Progressive familial intrahepatic cholestasis type 3 | 1.77e-04 | 3 | 228 | 2 | cv:C1865643 | |
| Disease | Cholestasis, benign recurrent intrahepatic 1 | 1.77e-04 | 3 | 228 | 2 | C4551899 | |
| Disease | red blood cell density measurement | DHRS3 RPN1 PSMD2 ATP8B1 PFKM PHGDH DST JAG1 ATP11A FGD5 PLEC PREX1 KLF11 DNAH10 ABCC6 THBS3 ZNF827 CROCC | 1.83e-04 | 880 | 228 | 18 | EFO_0007978 |
| Disease | reticulocyte measurement | RPN1 SPTB INSR PSMD2 PFKM MAP3K5 ABCB4 BLVRB FAT1 JAG1 ATP11A PREX1 MED12 DNAH10 KANK2 GARIN2 LIMS1 ZNF827 CTNND1 MYBPC1 | 2.14e-04 | 1053 | 228 | 20 | EFO_0010700 |
| Disease | ciliopathy (implicated_via_orthology) | 2.55e-04 | 40 | 228 | 4 | DOID:0060340 (implicated_via_orthology) | |
| Disease | Familial intrahepatic cholestasis of pregnancy | 3.53e-04 | 4 | 228 | 2 | C3489728 | |
| Disease | intrahepatic cholestasis (is_implicated_in) | 3.53e-04 | 4 | 228 | 2 | DOID:1852 (is_implicated_in) | |
| Disease | intrahepatic cholestasis (implicated_via_orthology) | 3.53e-04 | 4 | 228 | 2 | DOID:1852 (implicated_via_orthology) | |
| Disease | Jeune thoracic dystrophy | 3.53e-04 | 4 | 228 | 2 | cv:C0265275 | |
| Disease | Cholestasis, progressive familial intrahepatic 1 | 3.53e-04 | 4 | 228 | 2 | C4551898 | |
| Disease | Cleft Palate | 4.19e-04 | 81 | 228 | 5 | C0008925 | |
| Disease | Infiltrating duct carcinoma of female breast | 5.46e-04 | 21 | 228 | 3 | C3165106 | |
| Disease | Dystonia | 5.52e-04 | 86 | 228 | 5 | C0013421 | |
| Disease | monocyte:lymphocyte ratio | 5.85e-04 | 5 | 228 | 2 | EFO_0007956 | |
| Disease | apolipoprotein B measurement | DCHS2 PEX6 ABCA8 ABCB4 ANKDD1B DLG4 PLEC ARMC6 DNAH10 KANK2 RGS12 LIMS1 C6orf15 MTTP | 7.01e-04 | 663 | 228 | 14 | EFO_0004615 |
| Disease | aortic measurement | 7.89e-04 | 251 | 228 | 8 | EFO_0020865 | |
| Disease | Neurodevelopmental Disorders | 7.89e-04 | 93 | 228 | 5 | C1535926 | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 8.17e-04 | 24 | 228 | 3 | DOID:10595 (implicated_via_orthology) | |
| Disease | pappalysin-1 measurement | 8.74e-04 | 6 | 228 | 2 | EFO_0802845 | |
| Disease | sunburn | 9.11e-04 | 96 | 228 | 5 | EFO_0003958 | |
| Disease | mental development measurement | 9.24e-04 | 25 | 228 | 3 | EFO_0008230 | |
| Disease | hematocrit | CYB5D2 DHRS3 INSR PEX6 AKR1C4 ATP8B1 PFKM PHGDH FAT1 JAG1 PPP1R1B DLG4 FGD5 ABCC6 CEP164 THBS3 CDC5L CROCC | 9.33e-04 | 1011 | 228 | 18 | EFO_0004348 |
| Disease | sexual dimorphism measurement | EPPK1 INSR RGPD1 LHPP PTCH1 SNAP47 ABCA8 SPTBN5 PNPT1 ANKDD1B PLEC AKAP7 COL7A1 DNAH10 CEP164 ANKRD11 MACF1 CROCC PC | 1.03e-03 | 1106 | 228 | 19 | EFO_0021796 |
| Disease | Senior-Loken syndrome (is_implicated_in) | 1.22e-03 | 7 | 228 | 2 | DOID:0050576 (is_implicated_in) | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 1.22e-03 | 7 | 228 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | Renal dysplasia and retinal aplasia | 1.22e-03 | 7 | 228 | 2 | cv:C0403553 | |
| Disease | serine:glycine ratio | 1.22e-03 | 7 | 228 | 2 | EFO_0021777 | |
| Disease | Calcium channel blocker use measurement | 1.40e-03 | 213 | 228 | 7 | EFO_0009930 | |
| Disease | nicotine use, generational effect measurement, illegal drug consumption, non-substance related disinhibited behaviour, alcohol drinking, alcohol dependence | 1.43e-03 | 29 | 228 | 3 | EFO_0004329, EFO_0005430, EFO_0005431, EFO_0005432, EFO_0008364, MONDO_0007079 | |
| Disease | Cholestasis of pregnancy | 1.61e-03 | 8 | 228 | 2 | C0268318 | |
| Disease | Leigh syndrome | 1.61e-03 | 8 | 228 | 2 | cv:C0023264 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.61e-03 | 8 | 228 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | proteoglycan 3 measurement | 1.61e-03 | 8 | 228 | 2 | EFO_0802970 | |
| Disease | Ciliopathies | 1.67e-03 | 110 | 228 | 5 | C4277690 | |
| Disease | acute lymphoblastic leukemia | 1.72e-03 | 66 | 228 | 4 | EFO_0000220 | |
| Disease | Distal arthrogryposis | 2.06e-03 | 9 | 228 | 2 | cv:C0265213 | |
| Disease | response to clopidogrel, response to acetylsalicylate, major adverse cardiovascular event measurement | 2.06e-03 | 9 | 228 | 2 | EFO_0020863, GO_1903492, GO_1903493 | |
| Disease | dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 measurement | 2.57e-03 | 10 | 228 | 2 | EFO_0801544 | |
| Disease | apolipoprotein A 1 measurement | PEX6 AKR1C4 ANGPTL8 ADAR ABCA8 DUS2 TANGO6 COL7A1 DNAH10 KANK2 CEP164 MTTP MACF1 LRRFIP1 SORL1 | 2.62e-03 | 848 | 228 | 15 | EFO_0004614 |
| Disease | Intellectual Disability | 2.65e-03 | 447 | 228 | 10 | C3714756 | |
| Disease | non-alcoholic fatty liver disease (implicated_via_orthology) | 2.69e-03 | 36 | 228 | 3 | DOID:0080208 (implicated_via_orthology) | |
| Disease | Mammary Carcinoma, Human | PDE2A PPP1R12B ADAR PHGDH JAG1 FGD5 MED12 COL7A1 DYNC2H1 BIRC2 MTR | 2.73e-03 | 525 | 228 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | PDE2A PPP1R12B ADAR PHGDH JAG1 FGD5 MED12 COL7A1 DYNC2H1 BIRC2 MTR | 2.73e-03 | 525 | 228 | 11 | C1257931 |
| Disease | Mammary Neoplasms | PDE2A PPP1R12B ADAR PHGDH JAG1 FGD5 MED12 COL7A1 DYNC2H1 BIRC2 MTR | 2.81e-03 | 527 | 228 | 11 | C1458155 |
| Disease | Combined oxidative phosphorylation deficiency | 2.91e-03 | 37 | 228 | 3 | cv:C4540031 | |
| Disease | Jeune thoracic dystrophy | 3.12e-03 | 11 | 228 | 2 | C0265275 | |
| Disease | PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER) | 3.12e-03 | 11 | 228 | 2 | C4721541 | |
| Disease | Breast Carcinoma | PDE2A PPP1R12B ADAR PHGDH JAG1 FGD5 MED12 COL7A1 DYNC2H1 BIRC2 MTR | 3.29e-03 | 538 | 228 | 11 | C0678222 |
| Disease | Cleft upper lip | 3.39e-03 | 39 | 228 | 3 | C0008924 | |
| Disease | small cell lung carcinoma | 3.47e-03 | 80 | 228 | 4 | EFO_0000702 | |
| Disease | white matter microstructure measurement | 3.50e-03 | 390 | 228 | 9 | EFO_0005674 | |
| Disease | Candidemia | 3.73e-03 | 12 | 228 | 2 | EFO_1001282 | |
| Disease | Malignant neoplasm of breast | PDE2A PPP1R12B GSDMB ATP8B1 ADAR PHGDH JAG1 FGD5 MED12 COL7A1 DYNC2H1 BIRC2 THBS3 MTR MACF1 LRRFIP1 SORL1 | 4.31e-03 | 1074 | 228 | 17 | C0006142 |
| Disease | Zellweger Spectrum | 4.38e-03 | 13 | 228 | 2 | C3658299 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 4.38e-03 | 13 | 228 | 2 | C1846647 | |
| Disease | Zellweger-Like Syndrome | 4.38e-03 | 13 | 228 | 2 | C0751594 | |
| Disease | Infantile Refsum Disease (disorder) | 4.38e-03 | 13 | 228 | 2 | C0282527 | |
| Disease | ascending aortic diameter | 4.73e-03 | 140 | 228 | 5 | EFO_0021787 | |
| Disease | carpal tunnel syndrome | 5.08e-03 | 89 | 228 | 4 | EFO_0004143 | |
| Disease | eye disease | 5.09e-03 | 45 | 228 | 3 | EFO_0003966 | |
| Disease | homocysteine measurement | 5.41e-03 | 46 | 228 | 3 | EFO_0004578 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 5.84e-03 | 15 | 228 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Peroxisome biogenesis disorders | 5.84e-03 | 15 | 228 | 2 | C1832200 | |
| Disease | Adrenoleukodystrophy, Neonatal | 5.84e-03 | 15 | 228 | 2 | C0282525 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 5.84e-03 | 15 | 228 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 5.85e-03 | 276 | 228 | 7 | EFO_0004612, EFO_0020943 | |
| Disease | Colorectal Neoplasms | 5.97e-03 | 277 | 228 | 7 | C0009404 | |
| Disease | mean fractional anisotropy measurement | 6.39e-03 | 95 | 228 | 4 | EFO_0008399 | |
| Disease | diffusing capacity of the lung for carbon monoxide | 6.63e-03 | 96 | 228 | 4 | EFO_0009369 | |
| Disease | Zellweger Syndrome | 6.64e-03 | 16 | 228 | 2 | C0043459 | |
| Disease | Monogenic diabetes | 6.64e-03 | 16 | 228 | 2 | C3888631 | |
| Disease | obesity (implicated_via_orthology) | 6.70e-03 | 215 | 228 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 7.49e-03 | 17 | 228 | 2 | C0751883 | |
| Disease | Graves disease, thyrotoxic periodic paralysis | 7.49e-03 | 17 | 228 | 2 | EFO_0004237, MONDO_0019201 | |
| Disease | Moyamoya Disease | 7.49e-03 | 17 | 228 | 2 | C0026654 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 7.49e-03 | 17 | 228 | 2 | DOID:0060307 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RNRAVEVTKLAIEAG | 31 | P17516 | |
| LAAERKRGLQTEAQV | 221 | Q9P2B4 | |
| LKVREGQAVASTREL | 511 | Q96CN4 | |
| VEAGAVQLRADPAIK | 41 | Q92667 | |
| QAAEATKVAIDVGFR | 36 | Q5T2L2 | |
| IEVVDVATGRVKANA | 496 | Q8NCV1 | |
| KAELAATLGLSERQV | 216 | Q99626 | |
| VKVGQASEIARQTAE | 311 | Q99459 | |
| AVEAAKVGALASLIR | 191 | Q9Y646 | |
| LTAKLQGAEALDTVR | 841 | A0A096LP49 | |
| GALSAAEVEKRLAVR | 141 | P49703 | |
| ARRIKELISEGADVN | 181 | Q6UB99 | |
| NKLLVAGATVDARDL | 161 | Q86SG2 | |
| VAVAEAGELREQLKA | 441 | Q8TD16 | |
| AETANRTFQEKGILV | 196 | Q9P0M2 | |
| AILKVLVEAGAQLDV | 706 | Q8NFD2 | |
| LRAIAGNDDVKDAIV | 351 | Q6NXE6 | |
| NAAGVLVEARAKAIL | 321 | Q8TAX9 | |
| VDKTVAGQDAVIVLL | 61 | P30043 | |
| KTQLAEIEAQAALGR | 461 | Q2M329 | |
| EIEAQAALGRDILTK | 466 | Q2M329 | |
| GLEIAIKQRVDDALT | 426 | Q96M93 | |
| LGEVAQAQKVLRDSV | 116 | Q6UXH0 | |
| EAAALGDIREVQKLV | 16 | Q6AI12 | |
| GRAKVVADLESEQLL | 4176 | Q96M86 | |
| LEQEVVATGKEAARL | 936 | Q8TF21 | |
| AAFQVEKRLAVGALT | 146 | O75907 | |
| TAQAISDGDIKILVR | 851 | Q6DHV5 | |
| ATDAKVGSELIQVLA | 2856 | Q9H251 | |
| QEALRAQKATVSGEA | 211 | Q8TC90 | |
| QVLLEAVAIAAKGSI | 316 | Q14156 | |
| VLGVTAIKDLVDDVA | 151 | O43520 | |
| RLEDQVIGVALQASK | 616 | Q2KHR3 | |
| LVDTGRAAKLIQRAE | 1181 | Q99666 | |
| LVDTGRAAKLIQRAE | 1181 | O14715 | |
| TIVEGRKIEVNNATA | 161 | A6NFN3 | |
| EIAIQAAIGSKIIAR | 596 | Q8N442 | |
| KEVDTITAGINAQAR | 171 | Q96JH8 | |
| VAGDIIKAATELDRV | 811 | Q6NSI4 | |
| LKAVSSAAIAEVGRD | 881 | Q7Z5J8 | |
| SAAIAEVGRDNKEIQ | 886 | Q7Z5J8 | |
| ALIADGLANEAEKVR | 171 | Q8WWY6 | |
| EEQRAGTVIANVAKD | 31 | Q8TAB3 | |
| VDKLSGAVRIVQQLD | 976 | Q14517 | |
| AVGSVVLQVTALDKD | 1576 | Q14517 | |
| ALVAAKDGDVATLER | 6 | Q6ZVH7 | |
| AEKLRVAALVASGVA | 241 | Q96G91 | |
| SVAEVAAKARDTGIL | 176 | O00339 | |
| TAVKLARQSGIEDLV | 141 | Q7L5Y9 | |
| VSNGLKAIRVEAVSD | 86 | Q9BXT6 | |
| VSDADLQVLDGKIVA | 81 | Q9P2W1 | |
| AEGLSRLAKVVDEAL | 566 | Q9Y4C4 | |
| LSALGRLAEAAVAEK | 86 | Q8N201 | |
| VQADDVEVLKVGRTQ | 686 | Q8N201 | |
| VQALKRSARELIEGS | 6871 | Q03001 | |
| VSVADAEQRGENALK | 381 | P19013 | |
| LEEQLTAARARGDKV | 366 | Q9P219 | |
| IKGVETIANDVVSLA | 531 | P10515 | |
| EAVAIENIKRGLASL | 141 | P55157 | |
| LVTKVVAVDRDSGQN | 591 | Q9Y5H3 | |
| VDRAIALVGATFQKS | 121 | Q32MK0 | |
| SVIDISGLQRAVKEA | 56 | O00408 | |
| RLNIIIVAEGAIDKN | 256 | P08237 | |
| KLVFVGANEDRASQL | 866 | Q13608 | |
| RAGLQADLEVAAQKV | 986 | Q92817 | |
| KVEGQSRALVIAQEL | 886 | Q6ZNL6 | |
| GLADSLQLEKEVVRV | 371 | Q03052 | |
| GRIAQSAELADREKI | 1536 | O94854 | |
| AVIEGAVRSVKETLN | 66 | Q969V5 | |
| LADGVVSQAVKELIA | 96 | Q92917 | |
| SQNRIVDGAVFAVLK | 1211 | Q93074 | |
| AGVERIKVSQAAAEL | 21 | P50151 | |
| TAIAGSVEAVARLKR | 31 | Q9H008 | |
| VAAAKETVAIGRTDI | 121 | Q86XE3 | |
| NARDIIKGEAETRVA | 1041 | P06213 | |
| GEAVARVARKVNETV | 6 | Q8TCA0 | |
| KAILTAAIVDADRIA | 1241 | Q9Y5S2 | |
| IQEDAELGTAVALIK | 356 | Q9Y5G1 | |
| KVISSANRAVVGVVA | 156 | P62917 | |
| ALVNEVKAALGRALA | 2151 | Q7Z6Z7 | |
| VKGAQVDFSQELIRS | 116 | Q86U28 | |
| RVLSLLGADAVEQKA | 296 | O95672 | |
| AVKLGQAELVVIDEA | 376 | Q9H0A0 | |
| LKAAVLVANTVDREG | 386 | Q9NYA4 | |
| VQAALDKAREGRTTI | 571 | P21439 | |
| AAGKIATEAIENIRT | 891 | P21439 | |
| VVLVLSAVDKDEGLN | 1951 | Q6V1P9 | |
| LVVSRAALQALGVAE | 31 | O00459 | |
| QLVARKVAALSGDAR | 706 | Q13415 | |
| LVEQFQKLSEAAGRV | 101 | P40855 | |
| ARSIGVVEEKVSQNL | 26 | Q6UXA7 | |
| ARIKDAVQGFIINIE | 81 | Q96M91 | |
| GDLLRVADTIVAKAA | 1231 | Q8NCM8 | |
| ADAIAQAKRRGVVVF | 261 | O14531 | |
| VAEALTKAEAGRVEL | 706 | Q5TZA2 | |
| AVRDKEVVAVSVAGA | 61 | Q8WXF7 | |
| EALSELATAVKARIG | 181 | Q9BWL3 | |
| AETQAIVDEALGLRK | 231 | Q9Y6J0 | |
| KQEAADAALRVLIGE | 781 | P55265 | |
| LNTKDGRLVASLVAE | 66 | O95684 | |
| LAGKASRVDLETVAL | 816 | A6NNT2 | |
| ARLQAEVDEVIGSKR | 326 | Q9Y6A2 | |
| RLVNAIESKNAEGIF | 681 | O15078 | |
| EVLGLQRKLAEVEAA | 1201 | H7BZ55 | |
| RKLQEASGVADALQA | 1246 | H7BZ55 | |
| GVVDQALREAFQILK | 371 | Q7Z3S7 | |
| TVDKRTAIAAAAGVQ | 841 | Q7Z3S7 | |
| DVSLALTQRGVKVFA | 1761 | P12111 | |
| QLAEVAVSAKREALG | 536 | Q14055 | |
| TLEAVAALGNKVVES | 131 | Q12905 | |
| AALGNKVVESLRAQD | 136 | Q12905 | |
| DLNIVVVSVAGAFRK | 91 | Q8NHH9 | |
| EGSFKVLVATNVAAR | 436 | Q9BQ39 | |
| RLIEEKGAVDALAAA | 551 | Q9BQ39 | |
| QAARDSKITLFAIGV | 156 | Q96P44 | |
| SIEKLRALANGIEEV | 166 | O95236 | |
| VNQAGETALDIAKRL | 666 | Q9ULH1 | |
| KEAVLRAIDGINQRS | 36 | P49913 | |
| SAAVEALKEAGSIVR | 131 | P78352 | |
| GEAALAAKVAVLETQ | 281 | Q63ZY3 | |
| QAEVGKLNRIASAES | 486 | O14901 | |
| ESAIATVGAAIRRKE | 351 | Q9H078 | |
| NVDRLLETAGIKASA | 1941 | Q02388 | |
| KNLELAAVRGSDVRV | 61 | Q9BV79 | |
| ALAVARLVENDVAGI | 96 | Q9NX74 | |
| ADRGLSVLQKVLDTA | 151 | P42261 | |
| ARKADLAVAGLTITA | 491 | Q16099 | |
| AQASEISKALRREGI | 2526 | Q9BYK8 | |
| LQGRARELTVQKAEA | 151 | Q9BRJ6 | |
| EKVALQLLETAVARG | 3916 | Q8IVF4 | |
| QEAVSKVAAGERVVR | 316 | Q9Y694 | |
| VEKIDRQGAVAVTSA | 596 | Q9Y467 | |
| VVKAASGALRNLAVD | 726 | O60716 | |
| LERAKELNIDVVGVS | 181 | P11926 | |
| DNVTKAAVNLRREGV | 346 | A6NMZ7 | |
| REKVGDITILVNNAA | 111 | O75911 | |
| LGRASEVEVKNEIVA | 296 | Q32MZ4 | |
| LVDTGRAAKLIQRAE | 1166 | P0DJD0 | |
| KRDGNSSLIAAVAEV | 1041 | P78504 | |
| REVENVAITALEGLK | 186 | P17540 | |
| TDAARIGADAAQKQI | 126 | Q96G25 | |
| AGRDLSNQVRIAIKE | 696 | Q99683 | |
| IVELLVRNGADVNAK | 86 | Q8TAK5 | |
| GVTVVFENNDLIRAK | 286 | Q8N9W8 | |
| RAAILTKLQGAEEEI | 291 | Q5TCS8 | |
| QTLREALVAAGKEVI | 1251 | O14607 | |
| GEKSNVIVALARDSL | 111 | Q92673 | |
| RVASIETGLAAAAAK | 926 | O75151 | |
| KQLAIGVNEVTRALE | 111 | P78345 | |
| AKITAQEAVAGAAVL | 331 | Q9UHX1 | |
| GVAAAVDRATLTIDK | 441 | Q5SQN1 | |
| NDIRELKATGNIVEV | 196 | Q8N4U5 | |
| RKASAVGDVVNLVSV | 401 | O95255 | |
| AAVRNEAVVISGRKL | 31 | P13995 | |
| VAAGNALIQDTKEIA | 981 | Q9UPU3 | |
| GENKRFAADIISVLA | 116 | Q13200 | |
| GLAEVSKVAEQVLNA | 226 | Q9HB40 | |
| GLERADTAEKALNVI | 116 | Q0VDG4 | |
| LQEALRSVKAEIGQA | 396 | Q9BVG8 | |
| RSVKAEIGQAIEEVN | 401 | Q9BVG8 | |
| SVNDVLARAAAKGLL | 516 | Q8NE18 | |
| EAERVKAQVQALGLA | 421 | P29590 | |
| DAAEKGVRTLTAAAV | 61 | O60664 | |
| SALGVDIIAQVEAKD | 3111 | Q96Q15 | |
| RQKLSVDEAVDVGLV | 1946 | P58107 | |
| SAGVARKAAEEVTLQ | 121 | Q99707 | |
| VVVKSVQRGSLAEVA | 646 | Q8TCU6 | |
| TAIGDKNRRAVLALE | 1106 | Q13635 | |
| LVLKSAVEAERLVAG | 561 | P04843 | |
| GVQDALNIREAISKA | 531 | Q86TU7 | |
| IEKEQLDAQRVGVAA | 106 | Q8NG04 | |
| QALLEAGAKVVALES | 111 | Q9H5Q4 | |
| QAVEASAIAGVRAIV | 811 | Q8TE82 | |
| AAVAALLLGVVSREE | 161 | Q96GZ6 | |
| TLIVKAQGFRAVAEV | 496 | A6NM43 | |
| TLIVKAQGFRAVAEV | 496 | Q96SF2 | |
| AVNIVRETQSLDGAK | 941 | Q8NEZ3 | |
| NRVIEGDVVSALNKA | 256 | P48059 | |
| AASRGILDVQSVQEK | 36 | Q8NHG7 | |
| VEAAITRGLEANKLQ | 151 | Q8WUJ1 | |
| AVAVDLGNRKLEISS | 46 | Q8TCS8 | |
| RLSAIDVDKVAGAVD | 71 | Q86YF9 | |
| DVDKVAGAVDVLTLQ | 76 | Q86YF9 | |
| GRAQLDAISEKVDVI | 431 | Q5JPH6 | |
| LAQEVKAATERLSLG | 796 | Q5JTZ9 | |
| EVQAGKISALEATAR | 2626 | Q9NRC6 | |
| NIATIIKDGERATAL | 236 | Q86UX6 | |
| KGDAEVAITRLVDAL | 1391 | O94911 | |
| ARELIDTILVKGNAA | 506 | Q13490 | |
| AADRGNVELVETLLK | 341 | A6NHY2 | |
| GAASVDVVRLVEEVK | 351 | O75891 | |
| EGVALRSAKEFLVQQ | 1106 | Q9UPV0 | |
| SIVNVAQKRELGEAL | 151 | P56748 | |
| ADVIKTRLQVAARAG | 541 | Q9UJS0 | |
| REQTAKALARDNGIV | 211 | Q9GZX3 | |
| VALAVGRLADKSVLV | 406 | Q15021 | |
| LGATAVEDRLQEKAA | 656 | P98196 | |
| LETAIKQAAEQGARI | 61 | O95498 | |
| IAAQTAGIAAAARAK | 126 | P82912 | |
| KQDVGISAAFLADVR | 161 | P32780 | |
| QDSVVTARGLLDAKR | 126 | Q9BRP9 | |
| SKALGINRAERVVEE | 126 | O14924 | |
| AALALKQSSVAEEVG | 426 | Q9UH99 | |
| RIVAVTGAEAQKALR | 751 | P49588 | |
| VKFQRAITGASLADI | 76 | P83731 | |
| KTLIARAVANETGAF | 251 | P55072 | |
| AGKLVAIVDVIDQNR | 21 | P50914 | |
| AVDGNTVELKRAVSR | 71 | Q13151 | |
| LEASAVIQGLVKDRS | 321 | Q8IWA0 | |
| TTVELANKVGAAEII | 836 | O75533 | |
| ANKVGAAEIISRIVD | 841 | O75533 | |
| RVAELNDVTAKVASG | 41 | Q8WVD5 | |
| RVESAIKAVVDLNGR | 361 | Q96I25 | |
| RASREAVEKELGALQ | 401 | Q86SX3 | |
| AVQAAVSNLVRVGKE | 46 | P18206 | |
| VAKTDGEVQVRRAAI | 1006 | Q9C0B7 | |
| IDKQNVEALVARGAL | 336 | Q96N46 | |
| VNVIGLADDSVRSLK | 371 | Q4J6C6 | |
| VAGSILAKAQLEVTD | 396 | Q9HCK4 | |
| AAKVELVDIQREGAL | 186 | O14492 | |
| KLSGLERDVAAIQAR | 996 | P11277 | |
| AKAGERILILQEAVT | 2306 | Q86WI1 | |
| KDVLVGADSVRAAIT | 136 | O43760 | |
| GVARLSAEAEKVLAL | 1176 | Q15149 | |
| AEAERVLAEKLAAIG | 1966 | Q15149 | |
| AVAEKIRTALLTAGD | 41 | P49746 | |
| KRDVVGNDVATILSR | 461 | Q9Y6W5 | |
| AASALLVGRKDLVQV | 681 | Q6PJI9 | |
| AVLVEDLTQVLDKRG | 121 | P10073 | |
| EFIATIRAAKGLDQA | 86 | Q96GY0 | |
| LKEVAARAAGSLLAE | 291 | Q17R98 | |
| SRAVDGKIAEAVTLI | 346 | Q49AG3 | |
| RVASIETGLAAAAAK | 901 | Q9UPP1 | |
| ADVINAAEKLQVVGR | 61 | O43175 | |
| DNVDLEAATRKGILV | 81 | O43175 | |
| GSIRAVVNIFLVAKA | 376 | Q9H598 | |
| GAQEKVAEVRRSVDA | 311 | Q00G26 | |
| EVKNLRSGVSRAAVV | 1306 | Q9Y4F4 | |
| RDAAQVVVAGRSIFK | 36 | Q96S15 | |
| ALLEDSVIRQAKAAG | 141 | Q5H8A4 | |
| DSQAEVLKVIRQSAG | 136 | Q9UD71 | |
| QAAAALLKGRSVLDA | 246 | Q6PJF5 | |
| AVERAKQVTVGELNS | 106 | Q04725 | |
| DKVEARAIAIAAGVP | 151 | P11498 | |
| ALAEFRVRGVKTNIA | 446 | P11498 | |
| LVGAQAERRESLKAT | 51 | Q6P2D8 | |
| ADAILTKDNNIRVIG | 46 | Q6EMB2 | |
| EGITRNRTAQEKVAA | 296 | Q9BYX2 | |
| QAGIIAEKDANRTRL | 161 | Q6PEW1 | |
| IFVRVKAVNAAGASE | 806 | Q00872 | |
| ENAIVVVAGNKLRLD | 551 | Q14324 | |
| KLLARGADINTVNVD | 76 | O60237 |